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Abstract
This article is devoted to the asymptotic study of adaptive group sequential designs
in the case of randomized clinical trials with binary treatment, binary outcome and
no covariate. By adaptive design, we mean in this setting a clinical trial design
that allows the investigator to dynamically modify its course through data-driven
adjustment of the randomization probability based on data accrued so far, without
negatively impacting on the statistical integrity of the trial. By adaptive group
sequential design, we refer to the fact that group sequential testing methods can
be equally well applied on top of adaptive designs. Prior to collection of the data,
the trial protocol specifies the parameter of scientific interest. In the estimation
framework, the trial protocol also a priori specifies the confidence level to be used
in constructing frequentist confidence intervals for the latter parameter and the
related inferential method, which will be based on the maximum likelihood prin-
ciple. In the testing framework, the trial protocol also a priori specifies the null
and alternative hypotheses regarding the latter parameter, the wished type I and
type II errors, the rule for determining the maximal statistical information to be
accrued, and the frequentist testing procedure, including conditions for early stop-
ping. Furthermore, we assume that the protocol specifies a user-supplied optimal
unknown choice of randomization scheme, and we will focus on that randomiza-
tion scheme which minimizes the asymptotic variance of the maximum likelihood
estimator of the parameter of interest.
We obtain that, theoretically, the adaptive design converges almost surely to the
targeted unknown randomization scheme. In the estimation framework, we obtain
that our maximum likelihood estimator of the parameter of interest is a strongly
consistent estimator, and it satisfies a central limit theorem. We can estimate its
asymptotic variance, which is the same as that it would feature had we known in
advance the targeted randomization scheme and independently sampled from it.
Consequently, inference can be carried out as if we had resorted to independent
and identically distributed (iid) sampling. In the testing framework, we obtain that
the multidimensional t-statistics that we would use under iid sampling still con-
verges to the same canonical distribution under adaptive sampling. Consequently,
the same group sequential testing can be carried out as if we had resorted to iid
sampling. Furthermore, a comprehensive simulation study that we undertake vali-
dates the theory. It notably shows in the estimation framework that the confidence
intervals we obtain achieve the desired coverage even for moderate sample sizes.
In addition, it shows in the testing framework that type I error control at the pre-
scribed level is guaranteed, and that all sampling procedures only suffer from a
very slight increase of the type II error.
A three-sentence take-home message is: “Adaptive designs do learn the targeted
optimal design and inference and testing can be carried out under adaptive sam-
pling as they would under the targeted optimal randomization probability iid sam-
pling. In particular, adaptive designs achieve the same efficiency as the fixed ora-
cle design. This is confirmed by a simulation study, at least for moderate or large
sample sizes, across a large collection of targeted randomization probabilities.”
1 Introduction
This article is devoted to the asymptotic study of adaptive group sequential designs in the case
of randomized clinical trials with binary treatment, binary outcome and no covariate. Thus,
the experimental unit writes as O = (A, Y ) where the treatment A and the outcome Y are
dependent Bernoulli random variables. Typical parameters of scientific interest are Ψ+ = E(Y |A =
1)−E(Y |A = 0) (additive scale) or Ψ× = logE(Y |A = 1)− logE(Y |A = 0) (multiplicative scale,
which we will consider hereafter). One can interpret causally such parameters whenever one is
willing to postulate the existence of a full data structure X = (X(0), X(1)) containing the two
counterfactual outcomes under the two possible treatments and such that Y = X(A) and A
independent of X . If so indeed, Ψ+ = E(X(1))−E(X(0)) and Ψ× = logE(X(1))− logE(X(0)).
Let us know explain what we mean by adaptive group sequential design.
1.1 The notion of adaptive group sequential designs.
By adaptive design, we mean in this setting a clinical trial design that allows the investigator to
dynamically modify its course through data-driven adjustment of the randomization probability
based on data accrued so far, without negatively impacting on the statistical integrity of the trial.
This definition is slightly adapted from [10], the introductory article to the proceedings (to which
many articles cited below belong) of a workshop entitled “Adaptive clinical trial designs: Ready
for prime time?” held in October 2004, and jointly sponsored by the FDA and Harvard-MIT
Division of Health Science and Technology. Using the definition of prespecified sampling plans
given in [8], let us emphasize that we assume that, prior to collection of the data, the trial protocol
specifies: the parameter of scientific interest, and
• estimation framework: the confidence level to be used in constructing frequentist confidence
intervals for the latter parameter, the related inferential method;
• testing framework: the null and alternative hypotheses regarding the latter parameter, the
wished type I and type II errors, the rule for determining the maximal statistical information
to be accrued, the frequentist testing procedure (including conditions for early stopping).
Furthermore, we assume that the protocol specifies a user-supplied optimal unknown choice of
randomization scheme: our adaptive design does not belong to the class of prespecified sampling
schemes in that it targets the latter optimal unknown choice of randomization scheme, learning it
based on accrued data. We will focus in this article on maximum likelihood estimation and testing.
The considered user-supplied optimal unknown choice of randomization scheme will be that which
minimizes the asymptotic variance of our maximum likelihood estimator of the parameter of
interest. Even though other choices may be interesting (and dealt with along the same lines), we
feel strongly that minimizing the asymptotic variance of our estimator is a particularly sensible
choice, as it guarantees narrower confidence intervals and earlier decision to reject the null for its
alternative or not. Quoting James Hung of the FDA (about design adaptation in general — see
[14]), our adaptive design meets clearly stated objectives, it is certainly a “more careful planning,
not sloppy planning”.
By adaptive group sequential design, we refer to the fact that group sequential testing methods
can be equally well applied on top of adaptive designs. According to Hu and Rosenberg (quoting
from [13]), “The basic statistical formulation of a sequential testing procedure requires determin-
ing the joint distribution of the sequentially computed test statistics. Under response-adaptive
randomization, this is a difficult task. There has been little theoretical work done to this point,
nor has there been any evaluation of sequential monitoring in the context of sequential estimation
procedures [i.e. targeted adaptive designs] such as the double adaptive biased coin design.” These
authors end their final chapter with a quote from [22]: “Surprisingly, the link between response-
adaptive randomization and sequential analysis has been tenuous at best, and this is perhaps the
logical place to search for open research topics.” Indeed, we will determine the limit joint distri-
bution of the sequentially computed test statistics based on our results, and provide a theoretical
background to rely upon for adaptive design group sequential testing procedures.
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1.2 Bibliography.
The literature on adaptive designs is vast and we apologize for not including all of it. Quite
misleadingly, the expression “adaptive design” has also been used in the literature for sequential
testing and, in general, for designs that allow data-adaptive stopping times for the whole study
(or for certain treatment arms) which achieve the wished type I and type II errors requirements
when testing a null hypothesis against its alternative.
In the literature dedicated to what corresponds to our definition of adaptive design, such
adaptive designs are referred to as “response-adaptive randomization” designs (see the quote
from [13] above). Of course, data-adaptive randomization schemes have a long history, that goes
back to the 1930s, and we refer to Section 1.2 in [13] and Section 17.4 in [17] to provide the reader
with a comprehensive historical perspective.
The organization of the Section 1.1 illustrates the fact that we have decided to tackle separately
the group sequential testing problem from the data-adaptive determination of the randomization
probability in response to data collected so far — a choice justified by the fact that separating the
characterization of a group sequential testing procedure from the adaptation of the randomization
probability makes perfect sense from a methodological point of view. Resorting to the same
organization here is more delicate, because response-adaptive treatment allocation is indebted to
early studies in the context of sequential statistical analysis, such as [1, 6, 9] among many others.
However, the authors of [13] manage to trace back the idea of incorporating randomization in the
context of adaptive treatment allocation designs to [31].
On the one hand, regarding the adaptation of the randomization probability, data-adaptive
randomization schemes belong to either the “urn model” or “double adaptive biased coin” fam-
ilies (see the quote from [13] above), depending on whether the approach is nonparametric or
not. Adaptive designs based on urn models (so called because the randomization scheme can be
modeled after different ways of pulling various colored balls from an urn) notably include the
seminal “randomized play-the-winner rule” from the aforementioned article [31] or the more re-
cent “drop-the-loser rule” [15]; they do not target a specific user-supplied optimal unknown choice
of randomization scheme. The theory of this type of adaptive design is presented in detail in
chapter 4 of [13], with a comprehensive bibliography. On the contrary, targeting a specific user-
supplied optimal unknown choice of randomization scheme is the core of adaptive designs based
on flipping a (data-adaptively) biased coin. More precisely, the latter targeted randomization
scheme is expressed as a function f(θ) of an unknown parameter θ of the response model, and the
adaptive design is characterized by the sequence f(θn) which is based on updated estimates θn of
θ as the data accrue. For instance, the targeted randomization scheme we will consider (namely,
the minimizer of the asymptotic variance of our maximum likelihood estimator of the parameter
of interest in clinical trials with binary treatment, binary outcome and no covariate) is a function
of the two marginal probabilities of success. Again, the authors of [13] manage to trace back
this kind of procedure to [7]. A series of articles including [23, 12] address the theoretical study
of such adaptive designs, or investigate their properties based on simulations [11]. Overall, the
most relevant reference for our present article is certainly [13] (already cited many times), which
concerns asymptotic theory for likelihood-based estimation (not testing) based on data-adapted
randomization schemes in clinical trials.
On the other hand, regarding the group sequential testing problem, let us emphasize that we
consider the case where one starts with a large up-front commitment sample size and uses group
sequential testing to allow early stopping rather than starting out with a small commitment of
sample size and extending it if necessary — the latter distinction is taken from [20]. Therefore,
negative results obtained e.g. in [18, 25] for such procedures (inconveniently referred to as adaptive
designs methods in [20, 25]) that start out with a small commitment do not apply at all to our
procedure. On the contrary, we can build upon the thorough understanding of group sequential
methods as exposed in [17, 21], and more recently explored in [19].
Furthermore, there is also a rich literature on the Bayesian approach to adaptive designs. The
reader is referred to [4, 16, 3, 2] for further details.
Finally, this article builds upon the seminal technical report [26] which paves the way to robust
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and efficient estimation in randomized clinical trials thanks to adaptation of the design in a variety
of settings.
1.3 Forthcoming results in words.
We will state, prove and verify by simulation various properties of adaptive designs in the frame-
work of clinical trials with binary treatment, binary outcome and no covariate. Following the same
presentation as in Section 1.1, we obtain that the adaptive design converges almost surely to the
targeted unknown randomization scheme (Theorem 1), and that
• estimation framework:
– our maximum likelihood estimator of the parameter of interest is a strongly consistent
estimator (Theorem 1), it satisfies a central limit theorem (Theorem 2); we can estimate
its asymptotic variance, which is the same as that it would feature had we known in
advance the targeted randomization scheme and independently sampled from it (Theo-
rem 2); consequently, inference can be carried out as if we had resorted to independent
and identically distributed (iid) sampling;
– furthermore, the comprehensive simulation study that we undertake validates the the-
ory, notably showing that the confidence intervals we obtain achieve the desired coverage
even for moderate sample sizes;
• testing framework:
– the multidimensional t-statistics that we would use under iid sampling still converges to
the same canonical distribution under adaptive sampling (Theorem 3); consequently, the
same group sequential testing can be carried out as if we had resorted to iid sampling;
– furthermore, the comprehensive simulation study that we undertake validates the the-
ory, notably showing that type I error control at the prescribed level is guaranteed, and
that all sampling procedures only suffer from a very slight increase of the type II error.
A three-sentence take-home message is “Adaptive designs do learn the targeted optimal design
and inference and testing can be carried out under adaptive sampling as they would under the
targeted optimal randomization probability iid sampling. In particular, adaptive designs achieve
the same efficiency as the fixed oracle design. This is confirmed by a simulation study, at least for
moderate or large sample sizes, across a large collection of targeted randomization probabilities.”
In essence, everything works as predicted by theory. However, theory also warns us that gains
cannot be dramatic in the particular setting of clinical trials with binary treatment, binary out-
come and no covariate. Nonetheless, this article is important: it provides a theoretical template
and tools for asymptotic analysis of robust adaptive designs in less constrained settings, which
we will consider in future work. This notably includes the setting of clinical trials with covariate,
binary treatment, and discrete or continuous outcome, or the setting of clinical trials with covari-
ate, binary treatment, and possibly censored time-to-event among others. Resorting to targeted
maximum likelihood estimation [27] along with adaptation of the design provides substantial gains
in efficiency.
Finally, we want to emphasize that the whole adaptive design methodology that we develop
here is only relevant for clinical trials in which a substantial number of observations are available
before all patients are randomized. From now on, we assume that the clinical trial’s time scale
permits the application of the adaptive design methodology.
1.4 Organization of the article.
The article is organized as follows. We define the targeted optimal design in Section 2, and de-
scribe how to adapt to it in Section 3. The asymptotic study of the maximum likelihood estimator
of the parameter of interest under adaptive design is addressed in Section 4, focusing on strong
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consistency in Section 4.1 and on asymptotic normality in Section 4.2. In Section 5 we show how
a group sequential testing procedure can be applied on top of the adaptive design methodology.
We present the results of a simulation study in Sections 6 and 7. Section 6 is dedicated to the in-
vestigation of moderate and large sample size properties of the adaptive design methodology with
respect to estimation and assessment of uncertainty. Section 7 is dedicated to the performances
of the adaptive design group sequential testing methodology. In both sections, our data-adaptive
methodology is applied to a large collection of problems. How well the method performs is de-
termined across the collection of problems, which requires coming up with tailored tests that we
present in Appendix. In Appendix A.1 we present an important building block for consistency
results. It consists of a uniform Kolmogorov strong law of large numbers for martingales sums that
essentially relies on a maximal inequality for martingales. Another important building block for
central limit theorems is presented in Appendix A.2, where we derive a central limit theorem for
discrete martingales. The two tailored tests that we repeatedly use in Sections 6 and 7 in order to
evaluate the simulations are carefully described in Appendix A.3 and A.4. The latter tests provide
single p-values for multiple pairwise comparisons in the context of our simulations, notably dealing
with the multiplicity of elementary tests carried out. We conclude in Appendix A.5 with a series
of tables summarizing the results of the simulation study presented and interpreted in Sections 6
and 7.
Finally, in order to ease the reading, we highlight throughout the text the most important
results. We notably point out how to construct confidence intervals and how to apply a group
sequential testing procedure while targeting the optimal design and thus accruing observations
data-adaptively. We also stress in which terms the theoretical study and the simulations vali-
date the latter methods. Moreover, we compare the performances of the targeted optimal design
sampling scheme with those of the oracle iid sampling scheme (i.e. the targeted scheme). Seven
highlight are scattered in the article, respectively entitled
1. pointwise estimation and confidence interval (Section 4.2),
2. targeted optimal design adaptive group sequential testing (Section 5.1),
3. empirical validation of central limit theorem (Section 6.2),
4. empirical coverage of the confidence intervals (Section 6.3),
5. empirical widths of confidence intervals (Section 6.4),
6. empirical type I and type II errors (Section 7.2), and
7. empirical sample sizes at decision (Section 7.3).
2 Balanced versus optimal treatment mechanisms
2.1 The observed data structure and related likelihood.
We consider the simplest example of randomized trials, where an observation writes as O = (A, Y ),
A being a binary treatment of interest and Y a binary outcome of interest. We postulate the
existence of a full data structureX = (X(0), X(1)) containing the two counterfactual (or potential)
outcomes under the two possible treatments. The observed data structureO = (A,X(A)) = (A, Y )
only contains the outcome corresponding to the treatment the experimental unit did receive.
Therefore O is a missing data structure on X with missingness variable A.
We denote the conditional probability distributions of treatment A by
g(a|x) = P (A = a|X = x).
We assume that the randomization (or coarsening at random, abbreviated to CAR) assumption
holds: for all a ∈ A = {0, 1}, x ∈ X = {0, 1}2,
g(a|x) = P (A = a|X(a) = x(a)), (1)
4
http://biostats.bepress.com/ucbbiostat/paper258
We denote by G the set of such CAR conditional distributions of A given X , referred to as the set
of fixed designs. In the framework of this article, (1) is equivalent to
g(a|x) = g(a)
for all a ∈ A, x ∈ X : g ∈ G if and only if the random variables A and X are independent. We
only consider such treatment mechanisms in the rest of Section 2.
The distribution PX of the full data structure X has two marginal Bernoulli distributions
characterized by θ = (θ0, θ1) ∈]0, 1[2 with θ0 = EPXX(0) and θ1 = EPXX(1) (the only identifiable
part of PX). Therefore, introducing X (O) = {x ∈ X : x(A) = Y } (the set of full data structure
realizations compatible with O), the likelihood of O writes as
L(O) =
∑
x∈X (O)
P (O,X = x) =
∑
x∈X (O)
P (O|X = x)P (X = x)
=
∑
x∈X (O)
g(A|x)P (X = x) = g(A)P (X ∈ X (O))
= θYA (1− θA)1−Y g(A) = θ(O)g(A),
using the convenient shorthand notation θ(O) = θYA(1 − θA)1−Y . Because of the form of the
likelihood, we can say that the observed data structure O is obtained under (θ, g).
2.2 Efficient influence curve and efficient asymptotic variance for the
log-relative risk.
Say that the parameter of scientific interest is
Ψ(θ) = log
θ1
θ0
,
the log-relative risk; of course, the sequel straightforwardly applies to other choices, such as the
excess risk.
In a classical randomized trial, we would determine a (deterministic) treatment mechanism g
(therefore complying with CAR) and sample as many iid copies of O as necessary.
The theory of semiparametric statistics teaches us that the efficient influence curve for param-
eter θ0 under (θ, g) is
D⋆0(θ, g)(O) = (Y − θ0)
1l{A = 0}
g(0)
(2)
and that for parameter θ1 under (θ, g) is
D⋆1(θ, g)(O) = (Y − θ1)
1l{A = 1}
g(1)
. (3)
Then the delta-method (and page 386 in [28]) implies that the efficient influence curve for pa-
rameter Ψ(θ) under (θ, g) writes as
IC(θ, g)(O) = −1l{A = 0}
θ0g(0)
(Y − θ0) + 1l{A = 1}
θ1g(1)
(Y − θ1) (4)
so that the efficient asymptotic variance under (θ, g) is
Eθ,gIC(θ, g)
2(O) = Eθ,g
{
(Y − Eθ(Y |A))2
(
1l{A = 0}
θ20g(0)
2
+
1l{A = 1}
θ21g(1)
2
)}
=
σ2(θ)(0)
θ20g(0)
+
σ2(θ)(1)
θ21g(1)
=
1− θ0
θ0g(0)
+
1− θ1
θ1g(1)
with notation σ2(θ)(a) = Varθ(Y |A = a) = θa(1− θa), the conditional variance of Y given A = a.
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2.3 A relative efficiency criterion.
Defining OR(θ) = θ1/(1−θ1)θ0/(1−θ0) , the efficient asymptotic variance as a function of the treatment
mechanism g is minimized at the optimal treatment mechanism characterized by
g⋆(θ)(1) =
1
1 +
√
OR(θ)
=
√
θ0(1 − θ1)√
θ0(1− θ1) +
√
θ1(1− θ0)
, (5)
known as the Neyman allocation (see [13] page 13). Interestingly, g⋆(θ)(1) ≤ 12 whenever θ0 ≤
θ1, meaning that the Neyman allocation g
⋆(θ) favors the inferior treatment. The corresponding
optimal efficient asymptotic variance then writes as
v⋆(θ) =
(√
1− θ0
θ0
+
√
1− θ1
θ1
)2
.
In contrast, the standard balanced treatment characterized by gb(1) = 12 features an efficient
asymptotic variance
vb(θ) = 2
(
1− θ0
θ0
+
1− θ1
θ1
)
,
hence the relative efficiency criterion
R(θ) =
v⋆(θ)
vb(θ)
=
1
2
+
√
OR(θ)
1 + OR(θ)
∈ (12 , 1]. (6)
The definition of our relative efficiency criterion illustrates the fact that we decide to consider
the balanced treatment mechanism as a benchmark. We emphasize that any fixed design could
be chosen as benchmark treatment mechanism, with minor impact on the study we expose below.
It is worth noting that vb(θ) = v⋆(θ), or in other words that the so-called balanced treatment
mechanism is actually optimal, if and only if θ0 = θ1. In particular, there is no gain to expect
from adapting the treatment mechanism in terms of type I error control when testing the null
“Ψ(θ) = 0” against its negation. In addition, the following bound involving the relative efficiency
criterion on one side and the log-relative risk on the other holds:
R(θ) ≤ 1
2
+
√
eΨ(θ)
1 + eΨ(θ)
∈ (12 , 1].
0.0 0.2 0.4 0.6 0.8 1.0
0.
5
0.
6
0.
7
0.
8
0.
9
1.
0
θ1
R
(θ
)
Figure 1: Plot of the relative efficiency R(θ) as a function of θ1 for different values of θ0 (θ =
(θ0, θ1)). The solid, dashed and dotted curves respectively correspond to θ0 =
1
2 ,
1
10 ,
1
100 .
We present in Figure 1 three curves θ1 7→ R(θ) for three different values of θ0. It notably
illustrates that when θ0 is small, R(θ) can be significantly lower than 1 for values of Ψ(θ) which
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are not very large. For instance, θ = ( 1100 ,
5
100 ) yields Ψ(θ) ≃ 1.609, R(θ) ≃ 0.868 and optimal
treatment mechanism characterized by g⋆(θ)(1) ≃ 0.305. Were we given the optimal treatment
mechanism in advance, we would obtain confidence intervals (based on the central limit theo-
rem and Slutsky’s lemma) whose widths are approximately
√
R(θ) ≃ 0.931 times those of the
corresponding confidence intervals we would have got using the balanced treatment mechanism.
However the gain could actually be more dramatic than the previous example let think.
Let us consider again the testing setting: we want to test the null “Ψ(θ) = 0” against the
alternative “Ψ(θ) > 0” with type I error α and power (1 − β) at some user-defined alternative
ψ > 0.
Thanks to the delta-method, we know that the maximum likelihood estimator of Ψ(θ)
Ψn = log
∑n
i=1 Yi1l{Ai = 1}∑n
i=1 1l{Ai = 1}
− log
∑n
i=1 Yi1l{Ai = 0}∑n
i=1 1l{Ai = 0}
based on n iid copies Oi = (Ai, Yi) of O is asymptotically efficient. It is furthermore natural to
refer to
In =
n
s2n
,
the inverse of the estimated variance of Ψn at time n, as the statistical information available at
that time. Under ψ, the central limit theorem applies and teaches us that
√
In(Ψn−ψ) converges
in distribution, as n grows to infinity, to the standard normal distribution.
Deciding to reject the null if
√
InΨn ≥ ξ1−α yields a test with asymptotic type I error α. In
order to ensure that its asymptotic power at alternative ψ is (1 − β), it suffices to choose n such
as
n = inf
{
t ≥ 1 : It ≥
(
ξ1−α − ξβ
ψ
)2
= Imax
}
, (7)
Imax being the so-called maximum committed information.
For n large enough, In ≃ n/vb(θ) if we use the balanced treatment mechanism, while In
would have been approximately equal to n/v⋆(θ), had we used the optimal treatment mechanism.
Substituting bluntly n/vb(θ) or n/v⋆(θ) to In in (7), we see that the ratio of the testing times n
b
(using the balanced treatment mechanism) and n⋆ (using the optimal one) satisfies
n⋆
nb
≃ v
⋆(θ)
vb(θ)
= R(θ),
the relative efficiency criterion. In other words, were we given the optimal treatment mechanism
in advance, we would in average need to sample R(θ) ∈ (12 , 1) times the number of observations
required when using the balanced treatment mechanism. In the previous example where θ =
( 1100 ,
5
100 ), setting α = 0.05, β = 0.1 and the alternative parameter ψ = Ψ(θ) ≃ 1.609 > 0, the
maximal committed information is Imax ≃ 3.306, n⋆ ≃ 676.901 and nb ≃ 780.248.
In summary, resorting to the balanced treatment mechanism may be a very poor (inefficient)
choice. Since the optimal treatment mechanism g⋆(θ) can be learned from the data, why not use
it? Of course, targeting the optimal treatment mechanism on the fly implies losing independence
between successive observations, making the study of the design much more involved. However, we
present and study in the sequel such a methodology. It is built on the seminal technical report [26].
3 Targeting the optimal design
3.1 Adaptive coarsening at random assumption.
We denote by Ai, Xi = (Xi(0), Xi(1)), Yi = Xi(Ai) and Oi = (Ai, Yi) the treatment assignment,
full data structure, outcome, and observation for experimental unit i. Whereas X1, . . . , Xn are
7
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assumed iid, the random variables A1, . . . , An are not independent anymore since we want to adapt
the treatment mechanism based on past observations. Defining
An = (A1, . . . , An),
Xn = (X1, . . . , Xn),
On = (O1, . . . , On),
and for every i = 0, . . . , n
An(i) = (A1, . . . , Ai),
Xn(i) = (X1, . . . , Xi),
On(i) = (O1, . . . , Oi)
(with convention An(0) = Xn(0) = On(0) = ∅), let gn(·|Xn) denote the conditional distribution
of the design settings An given the full data Xn: by the chain rule,
gn(An|Xn) =
n∏
i=1
P (Ai|An(i− 1),Xn), (8)
hence the additional notation
gi(ai|a(i− 1),x) = P (Ai = ai|An(i− 1) = a(i− 1),Xn = x)
for all 1 ≤ i ≤ n, a = (a1, . . . , an) ∈ An, x = (x1, . . . , xn) ∈ Xn.
In this new setting, we state the following adaptive counterpart of the CAR assumption (1):
for all 1 ≤ i ≤ n, a ∈ An, x ∈ Xn, letting oi = (ai, xi(ai)) be the corresponding realization of
observation Oi,
gi(ai|a(i− 1),x) = P (Ai = ai|Xi = xi,On(i− 1) = o(i− 1))
= P (Ai = ai|Xi(ai) = xi(ai),On(i− 1) = o(i− 1)).
With obvious convention, the new adaptive randomization (or adaptive CAR) assumption also
writes as
gi(ai|a(i− 1),x) = gi(ai|xi,o(i− 1)) = gi(ai|xi(ai),o(i− 1)) (9)
for all 1 ≤ i ≤ n, a ∈ An, x ∈ Xn; it states that for each i Ai is conditionally independent of
the full data Xn given the observed data On(i − 1) for the first (i − 1) experimental units and
the full data Xi for the ith experimental unit, and in addition that the conditional probability of
Ai = ai given Xi and On(i− 1) actually only depends on the observed part Xi(ai) and On(i− 1).
In particular, (8) reduces to
gn(An|Xn) =
n∏
i=1
gi(Ai|Xi(Ai),On(i− 1)), (10)
which justifies the notation gn = (g1, . . . , gn). Note that in the framework of this article, a
treatment mechanism gn complies with the adaptive CAR assumption (10) if and only if, for all
1 ≤ i ≤ n, a ∈ An,x ∈ Xn,
gi(ai|a(i− 1),x) = gi(ai|o(i− 1)).
Note finally that we find useful to consider gi satisfying (9) as random element (through
On(i− 1)) of the set G of CAR designs.
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3.2 Data generating mechanism for adaptive design and likelihood.
Given the available dataOn(i−1) = (O1, . . . , Oi−1) at step i, one drawsXi from PX independently
of Xn(i − 1), then one calculates the conditional distribution gi(·|Xi,On(i− 1)) and samples Ai
given Xi from it, the next observation finally being Oi = (Ai, Xi(Ai)). Regarding the likelihood
of On, if
X (On) = {x ∈ Xn : xi(Ai) = Yi, i ≤ n}
= ⊗ni=1{x ∈ X : x(Ai) = Yi}
= ⊗ni=1X (Oi)
(the set of those realizations x of Xn compatible with On), then
L(On) =
∑
x∈X (On)
P (On,Xn = x)
=
∑
x∈X (On)
gn(An|x)P (Xn = x)
=
n∏
i=1
gi(Ai|Yi,On(i− 1))P (Xn ∈ X (On))
=
n∏
i=1
gi(Ai|Yi,On(i− 1))
n∏
i=1
θ(Oi), (11)
the third and fourth equalities being derived from the adaptive CAR equality (10) and from
independence of X1, . . . , Xn respectively. Thus, the likelihood remarkably factorizes into the
product of a θ-factor and a gn-factor. Thanks to the form of the likelihood, we can say that On is
obtained under (θ,gn). For convenience, we will also write sometimes that On is obtained under
gn-adaptive sampling scheme without specifying the parameter θ. Likewise, we will later refer to
data obtained under iid gb-balanced or under iid g⋆-optimal sampling schemes.
3.3 Strategy.
Let θi = (θi,0, θi,1) denote for each i ≤ n the maximum likelihood estimator of θ = (θ0, θ1) ∈]0, 1[2
based on On(i) (with convention θi,a =
1
2 as long as no relevant observation is available). Thanks
to the form of the log-likelihood exhibited in (11) and as soon as
∑i
j=1 1l{Aj = a} > 1, θi,a is the
empirical mean
θi,a =
∑i
j=1 Yj1l{Aj = a}∑i
j=1 1l{Aj = a}
,
as if we used a deterministic treatment mechanism (and observations were iid).
These empirical means yield plug-in estimates of σ2(θ)(a):
σ2i (a) = θi,a(1− θi,a),
as well as plug-in estimates of the optimal treatment mechanism g⋆(θ) introduced in (5), charac-
terized by gs1(1|On(0)) = 12 and for i ≥ 1,
gsi+1(1|On(i)) =
√
θi,0(1− θi,1)√
θi,0(1 − θi,1) +
√
θi,1(1 − θi,0)
(12)
(sometimes abbreviated to gsi+1(1)), hence a first adaptive CAR treatment mechanism g
s
n =
(gs1, . . . , g
s
n). Another interesting choice is also considered here, which we characterize iteratively
by g1(1|On(0)) = 12 and for i ≥ 1,
gi+1(1|On(i)) = argmin
γ∈(0,1)

 1i+ 1

 i∑
j=1
gj(1|On(j − 1)) + γ

− gsi (1)


2
. (13)
9
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This alternative choice aims at obtaining a balance between the two treatments which, at exper-
iment i, closely approximates g⋆(θ), in the sense that 1i
∑i
j=1 1l{Aj = 1} ≃ gsi−1(1), the current
best guess. This second definition is more aggressive in the pursuit of the optimal treatment
mechanism, as it tries to compensate on the fly for early sub-optimal sampling.
A technical condition was actually left aside in the definition of gsn. Because we want to exclude
the possibility that the adaptive design stops a treatment arm with probability tending to 1, we
impose that gi+1(1|On(i)) ∈ [δ; 1 − δ] for a small δ > 0 (such that δ < mina∈A g⋆(θ)(a) and
1− δ > maxa∈A g⋆(θ)(a)) by letting g⋆1(1|On(0)) = 12 and for i ≥ 1,
g⋆i+1(1|On(i)) = min
{
1− δ,max
{
δ,
√
θi,0(1− θi,1)√
θi,0(1 − θi,1) +
√
θi,1(1 − θi,0)
}}
(14)
(sometimes abbreviated to g⋆i+1(1)), thus characterizing the adaptive CAR treatment mechanism
g⋆n = (g
⋆
1 , . . . , g
⋆
n). Similarly, we substitute g
⋆
i (1) to g
s
i (1) and allow γ to vary in [δ, 1− δ] only in
(13), yielding another adaptive CAR treatment mechanism gan (where the superscript a stands for
aggressive).
In the rest of this article, we investigate theoretically and by intensive simulations the properties
of the data-adaptive designs based on g⋆n (g
a
n is only considered through the simulation study).
4 Asymptotic study
We address in this section the asymptotic statistical study of the method presented in the pre-
vious section. We derive strong consistency results in Section 4.1 and a central limit theorem in
Section 4.2.
4.1 Strong consistency.
The following consistency result holds, which teaches us that the method does learn what is the
optimal design.
Theorem 1. Let θn be the maximum likelihood estimator of θ ∈]0, 1[2 based on On sampled from
(θ,g⋆n), for the adaptive CAR treatment mechanism g
⋆
n characterized by (14). Then θn converges
almost surely to θ. Consequently, Ψn is a strongly consistent estimate of Ψ(θ) and g
⋆
n converges
to the optimal design g⋆(θ) in the sense that g⋆n(1) and
1
n
∑n
i=1 g
⋆
i (1) both converge almost surely
to g⋆(θ)(1).
Proof. Let us first introduce the following estimating function
D(ϑ)(O) = (D0(ϑ)(O), D1(ϑ)(O))
= ((Y − ϑ0)1l{A = 0}, (Y − ϑ1)1l{A = 1}). (15)
We also denote by Pθ,g⋆
i
the conditional distribution of Oi given On(i − 1), so that Pθ,g⋆
i
D(ϑ) =
E[D(ϑ)(Oi)|On(i− 1)].
For each i ≤ n
0 = Pθ,g⋆
i
D(θ) (16)
(according to the terminology introduced in [26], ϑ 7→ D(ϑ) is a martingale estimating function
for θ) while
0 =
1
n
n∑
i=1
D(θn)(Oi), (17)
because θn is the maximum likelihood estimator of θ. Equation (17) can be rearranged into
0 =
1
n
n∑
i=1
[
D(θn)(Oi)− Pθ,g⋆
i
D(θn)
]
+
1
n
n∑
i=1
Pθ,g⋆
i
D(θn)
10
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= Mn(D(θn)) +
1
n
n∑
i=1
Pθ,g⋆
i
D(θn),
which makes clear that if Mn(D(θn)) converges to 0 almost surely, then
1
n
∑n
i=1 Pθ,g⋆iD(θn) does
too. Furthermore,
Pθ,g⋆
i
D(θn) = ((θ0 − θn,0)g⋆i (0|On(i− 1)), (θ1 − θn,1)g⋆i (1|On(i− 1)))
whence 1n
∑n
i=1 Pθ,g⋆iD(θn) converges to 0 almost surely if and only if θn does to θ, since (14)
guarantees that 1n
∑n
i=1 g
⋆
i (a|On(i− 1)) ∈ [δ, 1− δ] for both a ∈ A.
Now, |Mn(D(θn))| is itself upper-bounded by
sup
ϑ∈[0,1]2
|Mn(D(ϑ))|
which converges to 0 almost surely by application of Theorem 8, justified by the fact that
supϑ∈[0,1] ‖D(ϑ)‖∞ < ∞ and because the standard entropy of F = {D(ϑ) : ϑ ∈ [0, 1]} for the
supremum norm satisfies H(F , ‖ · ‖∞, ε) = O(log 1/ε) (see [28], example 19.7).
Finally, the strong consistency of θn straightforwardly yields that g
⋆
n(1) converges almost surely
to g⋆(θ)(1), since the mapping θn 7→ g⋆n+1(1) is continuous. This in turn implies that the Cesa`ro
mean 1n
∑n
i=1 g
⋆
i (1) also converges almost surely to the same limit.
4.2 Asymptotic normality.
A central limit theorem.
We have established strong consistency of θn in the previous subsection. In order to provide
statistical inference, we need now to establish that
√
n(θn − θ) converges in distribution so that
one can construct confidence intervals for θ and come up with valid testing procedures. The
following central limit theorem actually holds.
Theorem 2. Let θn be the maximum likelihood estimator of θ ∈]0, 1[2 based on On sampled
from (θ,g⋆n), for the adaptive CAR treatment mechanism g
⋆
n defined in (14). Let D
⋆
0(θ, g
⋆(θ)),
D⋆1(θ, g
⋆(θ)) and IC(θ, g⋆(θ)) be as defined in (2), (3) and (4) with g = g⋆(θ). Let D⋆(θ, g⋆(θ)) =
(D⋆0(θ, g
⋆(θ)), D⋆1(θ, g
⋆(θ))). Then under (θ,g⋆n)
√
n(θn − θ) = 1√
n
n∑
i=1
D⋆(θ, g⋆(θ))(Oi)(1 + oP (1)). (18)
Furthermore, 1√
n
∑n
i=1D
⋆(θ, g⋆(θ))(Oi) is a normalized discrete martingale which converges under
(θ,g⋆n) to a centered Gaussian distribution with covariance matrix
Σ⋆ = Pθ,g⋆(θ)D
⋆(θ, g⋆(θ))⊤D⋆(θ, g⋆(θ))
= diag
(
θ0(1 − θ0)
g⋆(θ)(0)
,
θ1(1− θ1)
g⋆(θ)(1)
)
. (19)
The latter is consistently estimated with its empirical counterpart
1
n
n∑
i=1
D⋆(θn, g
⋆
n)
⊤D⋆(θn, g⋆n)(Oi)
=
1
n
n∑
i=1
diag
(
(Yi − θn,0)2 1l{Ai = 0}
g⋆n(0)
2
, (Yi − θn,1)2 1l{Ai = 1}
g⋆n(1)
2
)
(20)
as if the sampling was iid.
11
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Thus under (θ,g⋆n), we also have
√
n(Ψn −Ψ(θ)) = 1√
n
n∑
i=1
IC(θ, g⋆(θ))(Oi) + oP (1), (21)
and convergence in distribution of the normalized discrete martingale 1√
n
∑n
i=1 IC(θ, g
⋆(θ))(Oi) to
a centered Gaussian distribution with variance v⋆(θ), the optimal efficient asymptotic variance.
The latter is finally consistently estimated with either v⋆(θn) or
1
n
n∑
i=1
IC(θn, g
⋆
n)(Oi)
2 =
1
n
n∑
i=1
(
(Yi − θn,0)2 1l{Ai = 0}
θ2n,0g
⋆
n(0)
2
+ (Yi − θn,1)2 1l{Ai = 1}
θ2n,1g
⋆
n(1)
2
)
as if sampling was iid.
Construction of confidence intervals.
We wish to construct a confidence interval for Ψ(θ) based on On sampled under (θ,g
⋆
n). Let us
denote by s2n either consistent estimates of v
⋆(θ) based on On as introduced in Theorem 2, and
let ξ1−α/2 be the (1 − α/2)-quantile of the standard normal distribution. Thanks to the latter
theorem,
Highlight 1 (pointwise estimation and confidence interval). In view of Theorems 1 and 2, the
estimator Ψn of Ψ(θ) obtained under (θ,g
⋆
n) sampling scheme is strongly consistent, the estimated
probability of being treated g⋆n(1) also converging almost surely to the optimal probability of being
treated g⋆(θ)(1). In addition, the confidence interval[
Ψn ± sn√
n
ξ1−α/2
]
obtained under (θ,g⋆n) sampling scheme has asymptotic coverage (1− α).
This theoretical result is validated with simulations in Section 6.3.
Proof of Theorem 2.
Proof. As already seen in the proof of Theorem 1, 0 = 1n
∑n
i=1D(θn)(Oi) = Pθ,g⋆iD(θ) for every
i ≤ n, therefore yielding the following equality:
1√
n
n∑
i=1
(D(θn)(Oi)−D(θ)(Oi)) = − 1√
n
n∑
i=1
(
D(θ)(Oi)− Pθ,g⋆
i
D(θ)
)
. (22)
Defining g¯n(a) =
1
n
∑n
i=1 1l{Ai = a} for all a ∈ A straightforwardly implies that the left-hand side
quantity in (22) also writes as
√
n(θ−θn)∆n, with ∆n = diag(g¯n(0), g¯n(1)). Since g⋆n(0) and g⋆n(1)
are positive, it is almost sure that for n large enough, g¯n(0) and g¯n(1) are positive. We consider
such a sample size in the sequel. So the diagonal matrix ∆n is invertible, and equation (22) is
equivalent to
√
n(θn − θ) = 1√
n
n∑
i=1
(
D(θ)(Oi)− Pθ,g⋆
i
D(θ)
)
∆−1n , (23)
where obviously ∆−1n = diag(1/g¯n(0), 1/g¯n(1)). It remains to prove that ∆
−1
n converges in proba-
bility to a deterministic matrix in order to derive (18)
To this end, note that for both a ∈ A, g¯n(a) = 1nSn(a) + 1n
∑n
i=1 g
⋆
i (a) where Sn(a) =∑n
i=1(1l{Ai = a}−g⋆i (a)) is a discrete martingale sum. Since its increments are uniformly bounded,
Sn(a) converges almost surely and in mean square, hence
1
nSn(a) converges in probability to 0.
Because Theorem 1 ensures that 1n
∑n
i=1 g
⋆
i (a) converges to g
⋆(θ)(a) in probability, we conclude
12
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that ∆−1n converges in probability to the matrix ∆
−1
∞ = diag(1/g
⋆(θ)(0), 1/g⋆(θ)(1)). At this
stage, we obtain that (18) holds true.
Define Wn =
∑n
i=1 Pθ,g⋆iD
⋆(θ, g⋆(θ))⊤D⋆(θ, g⋆(θ)) and Σn = 1nEWn. One has
1
n
Wn = diag
(
θ0(1− θ0)
1
n
∑n
i=1 g
⋆
i (0)
g⋆(θ)(0)2
, θ1(1 − θ1)
1
n
∑n
i=1 g
⋆
i (1)
g⋆(θ)(1)2
)
.
Theorem 1 guarantees that 1n
∑n
i=1 g
⋆
i (a) converges almost surely to g
⋆(θ)(a) for both a ∈ A (and
consequently in L1 norm since 1n
∑n
i=1 g
⋆
i (a) ∈ [0, 1] for all n ≥ 1, by virtue of the dominated
convergence theorem), hence 1nWn converges in probability to Σ
⋆ as given by (19), and Σn con-
verges to Σ⋆ too. Therefore Theorem 10 applies and yields that 1√
n
∑n
i=1D
⋆(θ, g⋆(θ))(Oi) is a
normalized discrete martingale which converges under (θ,g⋆n) to a centered Gaussian distribution
with covariance matrix Σ⋆, as stated. Consequently, (18) can be rewritten as
√
n(θn − θ) = 1√
n
n∑
i=1
D⋆(θ, g⋆(θ))(Oi) + oP (1).
In addition, Theorem 10 teaches us that 1n
∑n
i=1D
⋆(θn, g
⋆
n)
⊤D⋆(θn, g⋆n)(Oi) consistently estimates
Σ⋆, and it is readily seen that (20) holds. We complete the proof by a straightforward application
of the delta-method.
5 Targeted optimal design group sequential testing
Obviously, the sequence of estimators (Ψn)n≥1 can be used to carry out the test of the null
“Ψ(θ) = ψ0” against its unilateral alternative “Ψ(θ) > ψ0” for some ψ0 ∈ R. We build in this
section a group sequential testing procedure, that is a testing procedure which repeatedly tries
to make a decision at intervals rather than once all data are collected, or than after every new
observation is obtained (such a testing procedure would be said fully sequential). We refer to
[17, 21] for a general presentation of group sequential testing procedures.
5.1 The targeted optimal design group sequential testing procedure.
Formal description of the targeted optimal design group sequential testing procedure.
We wish to test the null “Ψ(θ) = ψ0” against “Ψ(θ) > ψ0” with asymptotic type I error α and
asymptotic type II error β at some ψ1 > ψ0. We intend to proceed group sequentially with K ≥ 2
steps, and we wish to rely on a multidimensional t-statistic of the form
(T˜1, . . . , T˜K) =
(√
Nk(ΨNk − ψ0)
sNk
)
k≤K
, (24)
where each Nk is a carefully chosen (random) sample size and where s
2
n estimates the asymptotic
variance of
√
n(Ψn −Ψ(θ)) under (θ,g⋆n) sampling (see Theorem 2).
To this end, let 0 < p1 < . . . < pK = 1 be increasingly ordered proportions. Consider the
α-spending and β-spending strategies (α1, . . . , αK) and (β1, . . . , βK), i.e. K-tuples of positive
numbers such that
∑K
k=1 αk = α and
∑K
k=1 βk = β. One could for instance choose α-spending
and β-spending functions fα, fβ , that are increasing functions from [0, 1] to [0, 1] such that fα(0) =
fβ(0) = 0 and fα(1) = fβ(1) = 1, and set
∑k
l=1 αl = fα(pk)α,
∑k
l=1 βl = fβ(pk)β for all k ≤ K.
Now, let (Z1, . . . , ZK) follow the centered Gaussian distribution with covariance matrix C =
(
√
pk∧l/pk∨l)k,l≤K and let us assume that there exists a unique value I > 0, the so-calledmaximum
committed information from now on denoted by Imax, such that there exist a rejection boundary
(a1, . . . , aK) and a futility boundary (b1, . . . , bK) satisfying aK = bK , P (Z1 ≥ a1) = α1, P (Z1 +
ψ1
√
p1I ≤ b1) = β1, and for every 1 ≤ k < K,
P (∀j ≤ k, bj < Zj < aj and Zk+1 ≥ ak+1) = αk+1,
13
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P (∀j ≤ k, bj < Zj + ψ1
√
pjI < aj and Zk+1 + ψ1
√
pk+1I ≤ bk+1) = βk+1.
Note that the closer ψ1 is to ψ0, the larger is Imax (actually, ψ1 7→ ψ1
√
Imax is both upper
bounded and bounded away from zero). Heuristically, the closer ψ1 is to ψ0, the more difficult it
is to decide between the null and its alternative while preserving the required type II error at ψ1,
the more information is needed to proceed. In this setting, it is natural to refer to the inverse of
the variance of Ψn as an amount of statistical information collected so far. The latter information
writes as ns2
n
, notably making clear that the product s2nImax and number of observations n are on
the same scale.
In this spirit, let us finally define for each k ≤ K
Nk = inf
{
n ≥ 1 : n
s2n
≥ pkImax
}
.
Under (θ,g⋆n), if v
⋆(θ)Imax is large, then Nk tend to be large too.
The targeted optimal design group sequential testing rule finally writes as follows:
starting from k = 1,
if T˜k ≥ ak then reject the null and stop accruing data,
if T˜k ≤ bk then fail rejecting the null and stop accruing data,
if bk < T˜k < ak then set k ← k + 1 and repeat.
If (T˜1, . . . , T˜K) had the same distribution as (Z1, . . . , ZK), then the latter rule would yield a testing
procedure with the required type I error and type II error at the specified alternative parameter.
The merit is clear of targeting the fixed design g⋆(θ) that makes the estimate Ψn have the
optimal (i.e. smallest) asymptotic variance, the random variables Nk (i.e. successive number of
observations required for testing) then being, at least informally, stochastically smaller than they
would have been had another fixed design been used (or targeted).
Carrying out the targeted optimal design group sequential testing procedure.
We wish to test the null “Ψ(θ) = ψ0” against “Ψ(θ) > ψ0” with asymptotic type I error α and
asymptotic type II error β at some ψ1 > ψ0. We intend to proceed group sequentially with K ≥ 2
steps.
Highlight 2 (targeted optimal design adaptive group sequential testing). To do so:
1. Choose increasingly ordered proportions 0 < p1 < . . . < pK = 1.
2. Compute numerically the maximum committed information Imax, rejection and futility bound-
aries (a1, . . . , aK) and (b1, . . . , bK).
3. Starting from k = 1,
(a) keep sampling under (θ,g⋆n); as soon as Nk data are collected,
(b) compute T˜k,
(c) apply the following rule:
if T˜k ≥ ak then reject the null and stop accruing data,
if T˜k ≤ bk then fail rejecting the null and stop accruing data,
if bk < T˜k < ak then set k ← k + 1 and repeat.
We investigate the behavior of this group sequential testing procedure from a theoretical per-
spective in Section 5.2, and by simulations in Section 7, focusing on empirical type I and type II
errors in Section 7.2 and on empirical sample sizes at decision in Section 7.3.
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5.2 Asymptotic study of the targeted optimal design group sequential
testing procedure powered at local alternatives.
In order to tackle the asymptotic study of the targeted optimal design group sequential testing
procedure, we resort to contiguity arguments. According to Chapter 6 in [28], “contiguity argu-
ments are a technique to obtain the limit distribution of a sequence of statistics under underlying
laws Qn from a limiting distribution under laws Pn.” Here the laws Pn describe a null distri-
bution under investigation (the distribution of the test statistic under (θ,g⋆n)), and the laws Qn
correspond to an alternative hypothesis.
Proving the validity of the targeted optimal design group sequential testing procedure (as
defined in Section 5.1) powered at local alternatives is outside the scope of this article. We
rather consider a slightly simpler version where the random Nk are replaced by deterministic nk.
We conjecture that the theorem we prove in the simpler deterministic sample sizes context can
be extended to the random sample sizes context. The simulation study that we undertake in
Section 7 confirms the conjecture.
Once again, let 0 < p1 < . . . < pK = 1 be increasingly ordered proportions for some integer
K ≥ 2, and define nk = ⌈npk⌉ (the smallest integer not smaller than npk) for each k ≤ K. We
wish to the test the null against its alternative based on the multidimensional t-statistic
(T1, . . . , TK) =
(√
nk(Ψnk − ψ0)
snk
)
k≤K
(25)
(s2n estimates the asymptotic variance of
√
n(Ψn−Ψ(θ)) under (θ,g⋆n) — see Theorem 2). Before
going any further, we state a crucial theorem which describes how the test statistic converges
towards the so-called canonical distribution.
Theorem 3. Consider h = (h0, h1) ∈ R2 satisfying both h1 > h0 and γh1 + γ−1h0 6= 0 where
γ = OR(θ)g⋆(θ)(1)/g⋆(θ)(0). Define θh/
√
n = (θ0(1 + h0/
√
n), θ1(1 + h1/
√
n)) for all n ≥ n0
large enough to ensure θh/
√
n ∈]0, 1[2. The sequence (θh/√n)n≥n0 defines a sequence (ψn)n≥n0 of
contiguous parameters (“from direction h”), with ψn = Ψ(θh/
√
n) > Ψ(θ).
Introduce the mean vector µ(h) = (h1−h0)(√p1, . . . ,√pK)/
√
v⋆(θ) and the covariance matrix
C = (√pk∧l/pk∨l)k,l≤K . Then:
(i) under (θ,g⋆n), (T1, . . . , TK) converges in distribution, as n tends to infinity, to the centered
Gaussian distribution with covariance matrix C;
(ii) under (θh/
√
n,g
⋆
n), (T1, . . . , TK) converges in distribution, as n tends to infinity, to the Gaus-
sian distribution with mean µ(h) and covariance matrix C.
Say we want to perform a test such with asymptotic type I error α and asymptotic power
(1 − β) at the limit of the sequence of contiguous parameters (ψn)n≥n0 , i.e. such that (a) the
probability of rejecting the null for its alternative under (θ,g⋆n), and (b) the probability of failing
to reject the null for its alternative under (θh/
√
n,g
⋆
n) converge (as n tends to infinity) towards α
and β, respectively.
Consider the α-spending and β-spending strategies (α1, . . . , αK) and (β1, . . . , βK). It is usually
assumed that the next lemma holds:
Lemma 4. In the framework of Theorem 3, let (Z1, . . . , ZK) follow the centered Gaussian distri-
bution with covariance matrix C (as defined in Theorem 3). Assume that α + β < 1. There exits
a unique ε > 0, a unique rejection boundary (a1, . . . , aK), a unique futility boundary (b1, . . . , bK)
such that aK = bK , P (Z1 ≥ a1) = α1, P (Z1 + µ(εh)1 ≤ b1) = β1, and for every 1 ≤ k < K,
P (∀j ≤ k, bj < Zj < aj and Zk+1 ≥ ak+1) = αk+1,
P (∀j ≤ k, bj < Zj + µ(εh)j < aj and Zk+1 + µ(εh)k+1 ≤ bk+1) = βk+1.
Given such rejection and futility boundaries, we proceed as follows: starting from k = 1,
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if Tk ≥ ak then reject the null and stop accruing data,
if Tk ≤ bk then fail rejecting the null and stop accruing data,
if bk < Tk < ak then set k ← k + 1 and repeat
Theorem 3 and Lemma 4 teach us that the group sequential testing procedure described above
satisfies the requirements on stepwise type I and type II error control, once h is replaced with
εh (which actually corresponds to a shift in n in the definition of the sequence of contiguous
alternatives (θh/
√
n)n≥n0).
5.3 Proof of Theorem 3.
Theorem 3 is a corollary of the following
Lemma 5. Denote by Λn the log-likelihood ratio of the (θh/
√
n,g
⋆
n) experiment with respect to
the (θ,g⋆n) experiment, as defined in Theorem 3. There exists a constant τ
2 > 0 such that, under
(θ,g⋆n), the vector (
√
n1(Ψn1 − Ψ(θ)), . . . ,
√
nK(ΨnK − Ψ(θ)),Λn) converges in distribution, as n
tends to infinity, to the Gaussian distribution with mean (0, . . . , 0,− 12τ2) and covariance matrix

(√
pk∧l
pk∨l
v⋆(θ)
)
k,l≤K
√
v⋆(θ)µ(h)⊤√
v⋆(θ)µ(h) τ2

 .
In particular, the (θh/
√
n,g
⋆
n) and (θ,g
⋆
n) experiments are mutually contiguous.
It is easy to obtain the limiting distribution of (T1, . . . , TK) under (θ,g
⋆
n) from Lemma 5.
Le Cam’s third lemma solves the problem of obtaining the limiting distribution of (T1, . . . , TK)
under (θh/
√
n,g
⋆
n) from the convergence under (θ,g
⋆
n) exhibited in Lemma 5. The second limiting
distribution is still Gaussian, has the same asymptotic covariance matrix as under (θ,g⋆n), but
differs by its asymptotic mean which is no longer 0.
Proof of Theorem 3. By the continuous mapping theorem, we obtain from Lemma 5 the con-
vergence in distribution under (θ,g⋆n) of (
√
n1(Ψn1 − Ψ(θ)), . . . ,
√
nK(ΨnK − Ψ(θ))) to the cen-
tered Gaussian distribution with covariance matrix (v⋆(θ)
√
pk∧l/pk∨l)k,l≤K . Then Slutsy’s lemma
straightforwardly yield the first convergence (i).
Regarding (ii), we first invoke Lemma 5 and Le Cam’s third lemma (see Example 6.7 in [28])
in order to obtain that, under (θh/
√
n,g
⋆
n), the vector (
√
n1(Ψn1 −Ψ(θ)), . . . ,
√
nK(ΨnK −Ψ(θ)))
converges in distribution to the Gaussian distribution with mean
√
v⋆(θ)µ(h) and covariance
matrix (v⋆(θ)
√
pk∧l/pk∨l)k,l≤K . In addition, the (θh/√n,g
⋆
n) and (θ,g
⋆
n) experiments are mutually
contiguous, implying that if s2n estimates v
⋆(θ) under (θ,g⋆n), then it also estimates v
⋆(θ) under
(θh
√
n,g
⋆
n). We apply again Slutsky’s lemma in order to obtain the second convergence (ii).
Proof of Lemma 5. Let us consider first the log-likelihood ratio of the (θh/
√
n,g
⋆
n) experiment
with respect to the (θ,g⋆n) experiment. The shorthand notations θ(O) = θ
Y
A (1 − θA)1−Y and
θh/
√
n(O) = [θA(1 + hA/
√
n)]Y [1− θA(1 + hA/
√
n)]1−Y and (11) readily yield
Λn = log
n∏
i=1
g⋆i (Ai|Yi,On(i− 1))
g⋆i (Ai|Yi,On(i− 1))
n∏
i=1
θh/
√
n(Oi)
θ(Oi)
=
n∑
i=1
1l{Ai = 0}
[
Yi log
(
1 +
h0√
n
)
+ (1− Yi) log
(
1− θ0h0
(1− θ0)
√
n
)]
+1l{Ai = 1}
[
Yi log
(
1 +
h1√
n
)
+ (1− Yi) log
(
1− θ1h1
(1 − θ1)
√
n
)]
=
1√
n
n∑
i=1
L1(Oi)− 1
2n
n∑
i=1
L2(Oi) + oP (1),
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http://biostats.bepress.com/ucbbiostat/paper258
with
L1(Oi) = 1l{Ai = 0}Yi − θ0
1− θ0 h0 + 1l{Ai = 1}
Yi − θ1
1− θ1 h1,
L2(Oi) = 1l{Ai = 0}
[
Yi + (1 − Yi)
(
θ0
1− θ0
)2]
h20
+1l{Ai = 1}
[
Yi + (1− Yi)
(
θ1
1− θ1
)2]
h21.
First, we observe that, since L2 is bounded (and measurable),
1
n
∑n
i=1 L2(Oi) =
1
n
∑n
i=1 Pθ,g⋆i L2+
1
n
∑n
i=1[L2(Oi) − Pθ,g⋆i L2] = 1n
∑n
i=1 Pθ,g⋆i L2 + oP (1) by virtue of the Kolmogorov law of large
numbers. Now, Pθ,g⋆
i
L2 = g
⋆
i (0)
θ0h
2
0
1−θ0 + g
⋆
i (1)
θ1h
2
1
1−θ1 , hence
1
n
∑n
i=1 Pθ,g⋆i L2 =
1
n
∑n
i=1 g
⋆
i (0)
θ0h
2
0
1−θ0 +
1
n
∑n
i=1 g
⋆
i (1)
θ1h
2
1
1−θ1 = g
⋆(θ)(0)
θ0h
2
0
1−θ0 + g
⋆(θ)(1)
θ1h
2
1
1−θ1 + oP (1) by virtue of Theorem 1. In summary,
we obtain that
Λn =
1√
n
n∑
i=1
L1(Oi)− 1
2
τ2 + oP (1) (26)
for τ2 = g⋆(θ)(0)
θ0h
2
0
1−θ0 + g
⋆(θ)(1)
θ1h
2
1
1−θ1 .
Second, we define Zi = (1l{i ≤ n1}, . . . , 1l{i ≤ nK}) and introduce the bounded (and mea-
surable) function f such that f(Oi, Zi) = (ZiIC(θ, g
⋆(θ))(Oi), L1(Oi)). Let us show that Mn =
1
n
∑n
i=1[f(Oi, Zi)− Pθ,g⋆i f ] = 1n
∑n
i=1 f(Oi, Zi) (this equality holds because for all i ≤ n, one has
Pθ,g⋆
i
IC(θ, g⋆(θ)) = Pθ,g⋆
i
L1 = 0) satisfies a central limit theorem. In view of Theorem 10, letWn =∑n
i=1 Pθ,g⋆i f
⊤f and Σn = 1nEWn. The entries of matrixWn write either
∑nk
i=1 Pθ,g⋆i L1IC(θ, g
⋆(θ)),
or
∑nk∧nl
i=1 Pθ,g⋆i IC(θ, g
⋆(θ))2, or
∑n
i=1 Pθ,g⋆i L
2
1. Now,
• An =
∑nk
i=1 Pθ,g⋆i L1IC(θ, g
⋆(θ)) = h1g⋆(1)
∑nk
i=1 g
⋆
i (1) − h0g⋆(0)
∑nk
i=1 g
⋆
i (0), so that
1
nEAn =
pk(h1 − h0) + o(1) and 1nAn − 1nEAn = oP (1) since the almost sure convergence of the
bounded sequence 1n
∑n
i=1 g
⋆
i (a) towards g
⋆(θ)(a) (see Theorem 1) implies its convergence
in L1 norm to the same limit;
• Bn =
∑nk∧nl
i=1 Pθ,g⋆i IC(θ, g
⋆(θ))2 = 1−θ1θ1g⋆(θ)(1)2
∑nk∧nl
i=1 g
⋆
i (1) +
1−θ0
θ0g⋆(θ)(0)2
∑nk∧nl
i=1 g
⋆
i (0), hence
1
nEBn = pk∧l
(
1−θ1
θ1g⋆(θ)(1)
+ 1−θ0θ0g⋆(θ)(0)
)
+ o(1) = pk∧lv⋆(θ) + o(1) and 1nBn − 1nEBn = oP (1)
for the same reasons as above;
• Cn =
∑n
i=1 Pθ,g⋆i L
2
1 =
θ1h
2
1
1−θ1
∑n
i=1 g
⋆
i (1) +
θ0h
2
0
1−θ0
∑n
i=1 g
⋆
i (0), hence
1
nECn = τ
2 + o(1) and
1
nCn − 1nECn = oP (1) for the same reasons as above.
Those calculations notably teach us that, setting m = (h1−h0)(p1, . . . , pK) and Σ0 = (pk∧l)k,l≤K ,
Σn converges to
Σ =
(
v⋆(θ)Σ0 m
⊤
m τ2
)
.
Is Σ a positive definite covariance matrix? Well, Σ0 is a positive definite covariance matrix
(that of the vector (Bp1 , . . . , BpK ) where (Bt)t≥0 is a standard Brownian motion), hence the
symmetric matrix Σ is a positive definite covariance matrix if and only if its determinant det(Σ) >
0. Subtracting (h1 − h0)/v⋆(θ) times the Kth row of Σ to its last row, we get that det(Σ) =
v⋆(θ)K det(Σ0) × (τ2 − (h1 − h0)2/v⋆(θ)). Now, using v⋆(θ) = 1−θ0θ0g⋆(θ)(0) + 1−θ1θ1g⋆(θ)(1) and γh1 +
γ−1h0 6= 0 (required in Theorem 3) yields
v⋆(θ)τ2 − (h1 − h0)2
= h21
(
θ1v
⋆(θ)
1− θ1 g
⋆(θ)(1)− 1
)
+ h20
(
θ0v
⋆(θ)
1− θ0 g
⋆(θ)(0) − 1
)
+ 2h0h1
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= (γh1 + γ
−1h0)2 > 0.
In summary, Σ is a positive definite covariance matrix, the conditions of Theorem 10 are met,
and therefore
√
nMn =
1√
n
∑n
i=1 f(Oi, Zi) converges in distribution to the centered Gaussian
distribution with covariance matrix Σ.
Let ∆n = diag(
√
n/n1, . . . ,
√
n/nK , 1), ∆ = diag(1/
√
p1, . . . , 1/
√
pK , 1); obviously, ∆n =
∆+ o(1) and
√
nMn∆n =
√
nMn∆+ oP (1). Invoking (21) in Theorem 2 and (26), it holds that,
under (θ,g⋆n),
(
√
n1(Ψn1 −Ψ(θ)), . . . ,
√
nK(ΨnK −Ψ(θ)),Λn)
= (0, . . . , 0,− 12 τ2) +
√
nMn∆n + oP (1)
= (0, . . . , 0,− 12τ2) +
√
nMn∆+ oP (1).
This entails the convergence in distribution, under (θ,g⋆n), of (
√
n1(Ψn1 −Ψ(θ)), . . . ,
√
nK(ΨnK −
Ψ(θ)),Λn) to the Gaussian distribution with mean (0, . . . , 0,− 12τ2) and covariance matrix ∆Σ∆.
Simple calculations finally reveal that ∆Σ∆ equals the positive definite covariance matrix given
in the lemma.
6 Simulation study of the performances of targeted optimal
design adaptive estimation
In this section, we carry out a simulation study of the performances of targeted optimal design
adaptive procedures in terms of estimation and uncertainty assessment. The two main questions
at stake are “Do the confidence intervals obtained under the targeted optimal design adaptive
sampling scheme guarantee the desired coverage?” and “How well do they compare with the
intervals we would obtain under the targeted optimal iid sampling scheme?”
We carefully present the simulation scheme in Section 6.1. We validate with simulations the
central limit Theorem 2 that we derived theoretically in Section 4.2. The section culminates in
Section 6.3 with the investigation of the covering properties of the confidence intervals based on
the data-driven sampling schemes. Then, we consider the performances in terms of widths of the
confidence intervals in Section 6.4, Section 6.5 finally containing an illustration of the procedure.
6.1 The simulation scheme.
Define ε = 0.1 and the ε-net Θ0 = {(iε, jε) : 1 ≤ i ≤ j ≤ 9} over the set {(θ0, θ1) : ε ≤ θ0 ≤
θ1 ≤ 1− ε}. It has cardinality #Θ0 = 45. The log-relative risk function Ψ maps Θ0 onto the set
Ψ(Θ0) ⊂ [0; 2.1973], see Table 1, which is well described by its cumulative distribution function
(cdf) plotted in Figure 2. The set R(Θ0) ⊂ [0.6097; 1] is presented in Table 2. It is also interesting
to look in Figure 3 at the left-hand plot of {(Ψ(θ), R(θ)) : θ ∈ Θ0}. All θ ∈ Θ0 which are on the
diagonal are associated with a log-relative risk Ψ(θ) = 0 and a relative efficiency R(θ) = 1 and
are therefore represented by the single point (0, 1). It is also seen in the left-hand plot of Figure 3
that the relative efficiency R(θ) can be significantly lower than 1 even when Ψ(θ) is not large.
Table 3 and the two right-hand plots in Figure 3 are even more interesting, because our search
of efficiency relies for each θ ∈ Θ0 on targeting its optimal treatment mechanism g⋆(θ). In Table 3
we report the various optimal proportions of treated g⋆(θ)(1). In the two right-hand plots in
Figure 3, we represent the optimal proportion of treated g⋆(θ)(1) against the log-relative risk Ψ(θ)
(middle plot) and against the relative efficiency R(θ) (rightmost plot). Table 3 and the rightmost
plot in Figure 3 both illustrate the closed form equality
g⋆(θ)(1) =
1
2
(
1−
√
1
R(θ)
− 1
)
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θ .1 .2 .3 .4 .5 .6 .7 .8 .9
.1 0 0.693 1.099 1.386 1.609 1.792 1.946 2.079 2.197
.2 - 0 0.405 0.693 0.916 1.099 1.253 1.386 1.504
.3 - - 0 0.288 0.511 0.693 0.847 0.981 1.099
.4 - - - 0 0.223 0.405 0.560 0.693 0.811
.5 - - - - 0 0.182 0.336 0.470 0.588
.6 - - - - - 0 0.154 0.288 0.405
.7 - - - - - - 0 0.134 0.251
.8 - - - - - - - 0 0.118
.9 - - - - - - - - 0
Table 1: Values of Ψ(θ) for θ ∈ Θ0 (with precision 10−3).
θ .1 .2 .3 .4 .5 .6 .7 .8 .9
.1 1 0.962 0.904 0.850 0.800 0.753 0.708 0.662 0.610
.2 - 1 0.982 0.945 0.900 0.850 0.796 0.735 0.662
.3 - - 1 0.988 0.958 0.916 0.862 0.796 0.708
.4 - - - 1 0.990 0.962 0.916 0.850 0.753
.5 - - - - 1 0.990 0.958 0.9 0.800
.6 - - - - - 1 0.988 0.945 0.850
.7 - - - - - - 1 0.982 0.904
.8 - - - - - - - 1 0.962
.9 - - - - - - - - 1
Table 2: Values of R(θ) for θ ∈ Θ0 (with precision 10−3).
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Figure 2: Cumulative distribution function ψ 7→ 1#Θ0
∑
θ∈Θ0 1l{Ψ(θ) ≤ ψ} of Ψ(Θ0).
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which can be easily derived from (5) and (6) (using that g⋆(θ)(1) ≤ 12 because θ0 ≤ θ1). The
above equality, related table and figure teach us that more significant gains in terms of relative
efficiency R(θ) correspond to smaller optimal proportions of treated g⋆(θ)(1).
θ .1 .2 .3 .4 .5 .6 .7 .8 .9
.1 0.500 0.400 0.337 0.290 0.250 0.214 0.179 0.143 0.100
.2 - 0.500 0.433 0.380 0.333 0.290 0.247 0.200 0.143
.3 - - 0.500 0.445 0.396 0.348 0.300 0.247 0.179
.4 - - - 0.500 0.449 0.400 0.348 0.290 0.214
.5 - - - - 0.500 0.449 0.396 0.333 0.250
.6 - - - - - 0.500 0.445 0.380 0.290
.7 - - - - - - 0.500 0.433 0.337
.8 - - - - - - - 0.500 0.400
.9 - - - - - - - - 0.500
Table 3: Values of g⋆(θ)(1) for θ ∈ Θ0 (with precision 10−3).
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Figure 3: Plots of {(Ψ(θ), R(θ)) : θ ∈ Θ0} (left), {(Ψ(θ), g⋆(θ)(1)) : θ ∈ Θ0} (middle) and
{(R(θ), g⋆(θ)(1)) : θ ∈ Θ0} (right).
Let n = (100, 250, 500, 750, 1000, 2500, 5000) be a sequence of sample sizes. For every θ ∈ Θ0,
we estimate M = 1000 times the log-relative risk Ψ(θ) based on Omn7(ni), m = 1, . . . ,M, i =
1, . . . , 7, under
• iid (θ, gb)-balanced sampling,
• iid (θ, g⋆(θ))-optimal sampling,
• (θ,g⋆n7)-adaptive sampling,
• (θ,gan7)-adaptive sampling.
We choose δ = 0.01 in (14).
6.2 Empirical distribution of maximum likelihood estimates.
In Theorem 2 we proved that a central limit result holds for Ψn when targeting the optimal design,
as it is obviously the case under iid sampling. In order to check by simulations that remarkable
property and to determine how quickly the limit is reached, we propose the following procedure.
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Testing the empirical distribution of maximum likelihood estimates.
For every θ ∈ Θ0, all types of sampling, and each sample size ni, we compare the empirical
distribution of the (centered and rescaled) estimators of Ψ(θ)
Z(θ)ni,m =
√
ni
(
Ψni(O
m
n7(ni))−Ψ(θ)
)
√
v(θ)
, m = 1, . . . ,M
(where v(θ) = vb(θ) under balanced iid sampling and v(θ) = v⋆(θ) otherwise) with its standard
normal theoretical limit distribution in terms of two-sided Kolmogorov-Smirnov goodness-of-fit
test. This results in a collection of independent p-values {P (θ)cltni : θ ∈ Θ0, i = 1, . . . , 7} which
are uniformly distributed under the null hypothesis stating that all Z(θ)ni,m follow the standard
normal distribution.
Under the null, {P (θ)cltni : θ ∈ Θ0} contains iid copies of the Uniform distribution over [0; 1]
for every i = 1, . . . , 7. This statement can be tested in terms of one-sided Kolmogorov-Smirnov
goodness-of-fit procedure, the alternative stating that these iid random variables are stochastically
smaller than a uniform random variable, hence 7 final p-values for each sampling scheme as reported
in Table 4.
sample size
sampling scheme n1 n2 n3 n4 n5 n6 n7
iid gb-balanced p < 0.001 0.001 0.001 0.089 0.124 0.369 0.886
iid g⋆-optimal p < 0.001 0.001 0.612 0.094 0.381 0.764 0.947
g⋆n-adaptive p < 0.001 p < 0.001 0.027 0.060 0.042 0.156 0.123
gan-adaptive p < 0.001 p < 0.001 p < 0.001 0.003 0.006 0.136 0.460
Table 4: Checking the central limit theorem validity by simulation. We test if the independent
random variables {P (θ)cltni : θ ∈ Θ0} are uniformly distributed over [0; 1] according to the one-
sided Kolmogorov-Smirnov goodness-of-fit test, the alternative stating that they are stochastically
smaller than a uniform random variable: we report p-values for each sample size ni, i = 1, . . . , 7
and each sampling scheme.
Empirical validation of the central limit theorem.
It is not surprising that p-values are very small for smaller sample sizes n1, n2, n3. Considering
each sampling scheme (i.e. each row of Table 4) separately, we conclude that
the central limit theorem is not rejected under
• iid gb-balanced sampling for any sample size ni ≥ n4 = 750,
• iid g⋆-optimal sampling for any sample size ni ≥ n3 = 500,
• g⋆n-adaptive sampling for any sample size ni ≥ n3 = 500,
• gan-adaptive sampling for any sample size ni ≥ n6 = 2500,
adjusting for multiple testing in terms of the Benjamini and Yekutieli procedure for controlling
the False Discovery Rate at level 5%.
Less formally, the Gaussian limit theoretically guaranteed by the central limit theorem is
reached under iid g⋆-optimal and g⋆n-adaptive sampling schemes as soon as 500 observations are
accrued. The limit is reached as soon as 750 observations are collected when considering the iid
gb-balanced sampling scheme. This is a very satisfying result for the g⋆n-adaptive sampling scheme.
On the contrary, the limit is reached for a surprisingly large minimal sample size under gan-adaptive
sampling scheme. This said, we are less interested in the minimal sample size required to reach
the Gaussian limit than in the minimal sample size required to guarantee the desired coverage
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properties to our confidence intervals. The coverage properties of our confidence intervals are
investigated in Section 6.3.
In conclusion,
Highlight 3 (empirical validation of central limit theorem). In view of Theorem 2, the convergence
of
√
n(Ψn − Ψ(θ)) to its limit Gaussian distribution under adaptive (θ,g⋆n) sampling scheme is
empirically reached as soon as 500 observations are accrued. This is as good as what we get under
the iid (θ, g⋆) optimal sampling scheme.
Illustrating the convergence.
To give a sense of how well the standard normal limit distribution is reached, it is interesting to
consider, for each adaptive sampling scheme and for the corresponding first sample size for which
the central limit theorem is not rejected, that empirical cdf which is the farthest to the standard
normal limit cdf. How far an empirical cdf is from the standard normal cdf is measured in terms
of p-value of the two-sided Kolmogorov-Smirnov goodness-of-fit test. For a sample size n3 = 500
(the first sample size for which the central limit theorem is not rejected under the g⋆n-adaptive
sampling scheme; that first sample size is n6 = 2500 for the g
a
n-adaptive sampling scheme), it is
also interesting to compare the worse empirical cdf obtained under g⋆n-adaptive sampling scheme
to the worse empirical cdf obtained under gan-adaptive sampling scheme.
Thus, we represent in Figure 4 (left) the empirical cdf of the sequence (Z(θ−)n3,m)m≤M with
θ− = argminθ∈Θ0 P (θ)
clt
n3 under adaptive (θ
−,g⋆n3) sampling. We obtain θ
− = (0.3, 0.9) (for which
Ψ(θ−) = 1.0986). Even though P (θ−)cltn3 ≃ 0.0017, the empirical cdf and its limit are almost
superposable.
Similarly, we represent in Figure 4 (middle) the empirical cdf of the sequence (Z(θ′−)n6,m)m≤M
associated with θ′− = argminθ∈Θ0 P (θ)
clt
n6 under adaptive (θ
′−,gan6) sampling. We obtain θ
′− =
(0.1, 0.9) (for which Ψ(θ′−) = 2.1972). Again, the empirical cdf and its limit are almost superpos-
able.
Finally, we also represent in Figure 4 (right) the empirical cdf of the sequence (Z(θ−)n3,m)m≤M ,
that of the sequence (Z(θ′′−)n3,m)m≤M associated with θ
′′− = argminθ∈Θ0 P (θ)
clt
n3 under adaptive
(θ′′−,gan3) sampling, that is before the asymptotic distribution is reached for that design, and their
common limit. We obtain θ′′− = θ′− = (0.1, 0.9). A logarithmic scale is used on the y-axis in order
to enhance the differences occurring at the left tail. The Z(θ′′−)n3,m’s are visibly stochastically
(empirically) larger than the Z(θ′−)n3,m’s, themselves slightly stochastically (empirically) larger
than a standard normal random variable.
6.3 Empirical coverage of the confidence intervals.
We invoke the central limit theorem (Theorem 2) in order to construct confidence intervals for the
log-relative risk. The empirical validation of the theorem presented in Section 6.2 also provides us
with an indirect validation of the coverage properties of those confidence intervals. However it is
interesting to test directly if the coverage requirements are satisfied. Obviously, Section 6.3 is the
most important subsection of Section 6.
Testing the empirical coverage of the confidence intervals.
Set α = 5%. For every θ ∈ Θ0, all types of sampling, every iteration m and each sample size
ni, we estimate the asymptotic variance of the maximum likelihood estimator Ψni(O
m
n7(ni)) with
s(θ)2ni,m and build the confidence interval
I(θ)ni,m =
[
Ψni(O
m
n7(ni))±
s(θ)ni,m√
ni
ξ1−α/2
]
where ξ1−α/2 is the (1 − α/2)-quantile if the standard normal distribution. We are interested in
the empirical coverage guaranteed by I(θ)ni,m (its width will be considered in Section 6.4).
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Figure 4: Giving a sense of how well the standard normal limit distribution is reached under each
adaptive sampling scheme. Left: Under g⋆n-adaptive sampling scheme and for sample size n3 =
500, empirical cdf Fn3 (solid line) of the sequence (Z(θ
−)n3,m)m≤M whose empirical distribution
is the further from its limit standard normal distribution. The reference limit cdf F0 is also plotted
(dashed). Middle: Under gan-adaptive sampling scheme and for sample size n6 = 2500, empirical
cdf F ′n6 (solid line) of the sequence (Z(θ
′−)n6,m)m≤M whose empirical distribution is the further
from its limit standard normal distribution. The reference limit cdf F0 is also plotted (dashed).
Right: Empirical cdf Fn3 (solid line; it is the same as that plotted in the leftmost graph), empirical
cdf F ′′n3 (dotted line) of the sequence (Z(θ
′′−)n3,m)m≤M obtained under g
a
n-adaptive sampling
scheme whose empirical distribution is the further from its limit standard normal distribution,
and their common limit cdf F0 (dashed). In this last graph only, we use a logarithmic scale on the
y-axis in order to enhance the differences at the left tail.
Empirical coverage of intervals I(θ)ni,m,m = 1, . . . ,M , that is proportions
c(θ)ni =
1
M
M∑
m=1
1l{Ψ(θ) ∈ I(θ)ni,m}, θ ∈ Θ0, i = 1, . . . , 7,
are reported in Tables 12 and 13 (for i = 1, 2, 3, 4 and i = 5, 6, 7 respectively) for iid gb-balanced
sampling, in Tables 14 and 15 (for i = 1, 2, 3, 4 and i = 5, 6, 7 respectively) for iid g⋆-optimal
sampling, in Tables 16 and 17 (for i = 1, 2, 3, 4 and i = 5, 6, 7 respectively) for g⋆n-adaptive
sampling, and in Tables 18 and 19 (for i = 1, 2, 3, 4 and i = 5, 6, 7 respectively) for gan-adaptive
sampling.
Because those tables are very dense, we invite the reader to skim through them and rather
comment on Figure 5 before testing if the empirical coverage behaves as it should.
In Figure 5, the leftmost boxplot at each sample size (associated to iid gb-balanced sampling
scheme) serves as a benchmark. There is no striking difference between them and the corresponding
boxplots associated to iid g⋆-optimal sampling. Surprisingly, a rather good coverage is guaranteed
at sample sizes n1 = 100, n2 = 250, i.e. even before the central limit theorem is empirically
validated (see Section 6.2). In contrast, the boxplots associated to the adaptive designs reveal
a very poor empirical coverage at the smallest sample sizes n1 = 100 and n2 = 250. When
the sample size is larger than or equal to n3, the boxplots associated to the adaptive designs
illustrate an empirical coverage that compares equally to that of the independent designs. This
is in agreement with the empirical validation of the central limit theorem for g⋆n-adaptive design,
but not for gan-adaptive design.
More rigorously now, the independent rescaled empirical coverage proportions {Mc(θ)ni : θ ∈
Θ0} should be distributed according to the Binomial distribution with parameter (M, 1− a) with
a = α for every i = 1, . . . , 7. This property can be tested in terms of our tailored test (see
Section A.3), the alternative stating that a > α. This results in a collection of 7 p-values for each
sampling scheme, as reported in Table 5.
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Figure 5: Boxplots representing the empirical coverage proportions {c(θ)ni : θ ∈ Θ0} for i =
1, . . . , 7 (each sample size) and each sampling scheme: from left to right at each sample size,
iid gb-balanced, iid g⋆-optimal, g⋆n-adaptive and g
a
n−adaptive sampling schemes. Every box fea-
tures a solid horizontal line showing the mean value, its bottom and top limits corresponding to
the first and third quartiles. Its whiskers extend to the most extreme data point which is no more
than 1.5 times the interquartile range. An horizontal line indicating the aimed level 95% is added.
sample size
sampling scheme n1 n2 n3 n4 n5 n6 n7
iid gb-balanced 0.498 0.966 0.923 0.247 0.369 0.045 0.925
iid g⋆-optimal 0.995 0.981 0.769 0.533 0.958 0.586 0.007
g⋆n-adaptive p < 0.001 p < 0.001 0.218 0.160 0.722 0.645 0.179
gan-adaptive p < 0.001 p < 0.001 0.028 0.009 0.425 0.898 0.717
Table 5: Checking the adequateness of the coverage guaranteed by our simulated confidence
intervals. We test if the independent rescaled empirical coverage Binomial random variables
{Mc(θ)ni : θ ∈ Θ0} have parameter (M, 1 − α), the alternative stating that they have parameter
(M, 1− a) with a > α: we report p-values for each sample size ni, i = 1, . . . , 7 and each sampling
scheme. The tailored test used here is presented in Section A.3.
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Empirical validation of the coverage of the confidence intervals.
Considering each sampling scheme (i.e. each row of Table 5) separately, we conclude that
the (1− α)-coverage cannot be declared defective under
• iid gb-balanced sampling for any sample size ni,
• iid g⋆-optimal sampling for any sample size ni,
• g⋆n-adaptive sampling for any sample size ni ≥ n3 = 500,
• gan-adaptive sampling for any sample size ni ≥ n4 = 750,
adjusting for multiple testing in terms of the Benjamini and Yekutieli procedure for controlling
the False Discovery Rate at level 5%. Note that the coverage validity under iid optimal sampling
for the largest sample size n7 = 5000 is barely obtained.
Less formally, the confidence intervals obtained under both iid sampling schemes achieve the
desired coverage for any sample size (that is as soon as 100 observations are collected). Satisfac-
torily, the confidence intervals obtained under g⋆n-adaptive sampling scheme achieve the desired
coverage when the sample size exceeds n3 = 500 (indeed, most numbers in Tables 16 and 17 are
very close to 0.95 for i = 3, 4, 5, 6, 7). Regarding the gan-adaptive sampling scheme, n4 = 750
accrued data at least are required to guarantee the desired coverage of the confidence intervals.
This is much better than the minimal sample size of n6 = 2500 necessary to reach the Gaussian
limit in the central limit theorem (see Section 6.2).
In conclusion,
Highlight 4 (empirical coverage of the confidence intervals). In view of Theorem 2 and its im-
plications in terms of construction of confidence intervals, the confidence intervals that we obtain
under adaptive (θ,g⋆n) sampling scheme achieve the desired coverage as soon as 500 observations
are accrued. In contrast, the confidence intervals we get under the iid (θ, g⋆) optimal sampling
scheme feature the desired coverage as soon as 100 observations are collected.
6.4 Empirical widths of the confidence intervals.
Now we know that, for moderate and large sample sizes, the confidence intervals we obtain under
both adaptive sampling schemes meet the coverage requirements. In this subsection, we investigate
the empirical widths of the confidence intervals. We expect to show that the confidence intervals
obtained under adaptive sampling schemes are narrower than those obtained under iid gb-balanced
sampling scheme, and also that they are not significantly wider than the confidence intervals
obtained under the iid g⋆-optimal sampling scheme.
So we focus here on the empirical widths of intervals I(θ)ni,m. A preliminary inspection
teaches us that the empirical distributions of the widths {|I(θ)ni,m| : m = 1, . . . ,M} are unimodal
and roughly symmetric at the mode (this is not a surprise, at least under iid sampling: the
squared width |I(θ)ni,m|2 is proportional to s(θ)2ni,m/ni and
√
n(s(θ, g)2−v(θ, g)) is asymptotically
normal). It is therefore meaningful to report only means and standard deviations. So we introduce
the quantities
r(θ)ni,m =
s(θ)ni,m√
v⋆(θ)
− 1
(s(θ)ni,m/
√
v⋆(θ) is the ratio of the width of I(θ)ni,m over its optimal width), and report the
empirical mean and standard deviation of {r(θ)ni,m : m = 1, . . . ,M} in Tables 20 and 21 (for
i = 1, 2, 3, 4 and i = 5, 6, 7 respectively) for iid gb-balanced sampling, in Tables 22 and 23 (for
i = 1, 2, 3, 4 and i = 5, 6, 7 respectively) for iid g⋆-optimal sampling, in Tables 24 and 25 (for
i = 1, 2, 3, 4 and i = 5, 6, 7 respectively) for g⋆n-adaptive sampling, and in Tables 26 and 27 (for
i = 1, 2, 3, 4 and i = 5, 6, 7 respectively) for gan-adaptive sampling.
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We start with qualitative comments. As expected, empirical means on the diagonal of every
table quickly decrease to 0 when the sample size increases (for such θ’s, the iid gb-balanced sampling
is optimal). We also remark that for every sampling scheme and θ ∈ Θ0, the corresponding
empirical means converge towards
√
vb(θ)/v⋆(θ)−1 (for iid gb-balanced sampling) or 0 (otherwise)
while the corresponding standard deviations decrease as the sample size increases: this is due to
the convergence of s(θ)2ni,m towards v
b(θ) (for iid gb-balanced sampling) or v⋆(θ) (otherwise).
So this simulation study seems to confirm that it is possible indeed, as theoretically proven in
Section 4.2, to get confidence intervals of asymptotic level (1 − α) as narrow as the optimal ones
that we would obtain, had we known in advance the corresponding optimal treatment mechanism
characterized by (5).
Testing the empirical widths of confidence intervals.
Now, the latter qualitative comments are backed by quantitative results that we obtain in a testing
framework. On one hand indeed, the widths {|I(θ)ni,m| : m = 1, . . . ,M} of the M confidence
intervals obtained under iid g⋆-optimal sampling provide us with an empirical counterpart of a
benchmark distribution of optimal width for sample size ni. On the other hand the distributions
of the widths of the confidence intervals at sample size ni obtained under both adaptive sampling
schemes are the empirical counterparts of two distributions which may be close to the empirical
benchmark distribution (at least, the theory teaches us that the empirical distributions under iid
g⋆-optimal sampling and g⋆n-adaptive sampling schemes converge, as the sample size increases, to
the the same Dirac probability distribution). Similarly, the rescaled widths {√R(θ)|I(θ)ni,m| :
m = 1, . . . ,M} of the M confidence intervals obtained under iid gb-balanced sampling give rise
to the empirical counterpart of a distribution which should be close to the empirical benchmark
distribution (at least again, the theory teaches us that the empirical distributions under iid optimal
and balanced sampling schemes converge, as the sample size increases, to the the same Dirac
probability distribution).
Therefore we can test at each sample size and across Θ0, in terms of our tailored test for
comparison of widths (see Section A.4), if for each intermediate sample size the two distributions
of widths under both adaptive sampling schemes coincide with the benchmark distribution (null),
rather than being stochastically larger (alternative hypothesis). This yields 14 p-values all almost
equal to one, see Table 6. In other words, no matter the sample size, we cannot conclude that the
widths of the confidence intervals obtained under either adaptive sampling scheme are larger than
their counterparts obtained under iid g⋆-optimal sampling.
Regarding the comparison of the iid gb-balanced and g⋆-optimal sampling schemes, we can
test at each sample size and across Θ0, in terms of our tailored test for comparison of widths (see
Section A.4), if for each intermediate sample size the distribution of rescaled widths under iid
gb-balanced sampling scheme coincides with the benchmark distribution (null), rather than being
stochastically smaller (alternative hypothesis). This yields 7 p-values all smaller than 10−6. In
other words, no matter the sample size, we can conclude that the widths of the confidence intervals
obtained under iid g⋆-optimal sampling scheme are stochastically larger than their rescaled (by
the corresponding factor
√
R(θ)) counterparts obtained under iid gb-balanced sampling for some
θ ∈ Θ0. This is not very surprising: rescaling is meant here to adjust the means, the variances
being for instance possibly still different for some θ ∈ Θ0.
However we can slightly adapt the procedure we just presented, rescaling more modestly by a
sub-optimal factor. We compare now, in the same terms, the empirical benchmark distributions
of optimal width with the empirical distributions of {√R(θ)ρ|I(θ)ni,m| : m = 1, . . . ,M} under
iid gb-balanced sampling for the arbitrarily chosen ρ = 0.9. We obtain the 7 p-values reported in
Table 6.
Empirical validation of the widths of confidence intervals.
Considering each sampling scheme (i.e. each row of Table 6) separately, we conclude that
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sample size
sampling scheme n1 n2 n3 n4 n5 n6 n7
iid gb-balanced p < 0.001 0.018 0.025 0.149 0.588 1.000 0.997
g⋆n-adaptive 1.000 1.000 1.000 1.000 1.000 1.000 0.977
gan-adaptive 1.000 1.000 1.000 0.999 0.995 1.000 1.000
Table 6: Comparing the widths of our confidence intervals. First row: We report p-values de-
rived at each sample ni, i = 1, . . . , 7 when comparing, across Θ0, the empirical distributions of
rescaled widths (by a factor
√
R(θ)
ρ
with ρ = 0.9) under iid gb-balanced sampling to the em-
pirical distributions of widths obtained under iid g⋆-optimal sampling, in terms of our tailored
test for comparison of widths (see Section A.4), the alternative hypothesis stating that the latter
are stochastically larger than the former. Second and third rows: We report p-values derived at
each sample ni, i = 1, . . . , 7 when comparing, across Θ0, the empirical distributions of widths
obtained under g⋆n-adaptive sampling (second row), or under g
a
n-adaptive sampling (third row),
to the empirical distributions of widths obtained under iid g⋆-optimal sampling, in terms of our
tailored test for comparison of widths (see Section A.4), the alternative hypothesis stating in both
cases that the latter are stochastically smaller than the former distributions.
• the confidence intervals produced under iid gb-balanced sampling and rescaled by the cor-
responding factor of the form
√
R(θ)
ρ
(ρ = 0.9) are not stochastically narrower than those
produced under iid g⋆-optimal sampling for any sample size ni ≥ n2 = 250,
• the confidence intervals produced under g⋆n-adaptive sampling are not stochastically wider
than those produced under iid g⋆-optimal sampling for any sample size ni,
• the confidence intervals produced under gan-adaptive sampling are not stochastically wider
than those produced under iid g⋆-optimal sampling for any sample size ni,
adjusting for multiple testing in terms of the Benjamini and Yekutieli procedure for controlling
the False Discovery Rate at level 5%.
In conclusion,
Highlight 5 (empirical widths of confidence intervals). In view of Theorem 2 and for any sample
size, the widths of the confidence intervals obtained under adaptive (θ,g⋆n) sampling scheme are
not significantly greater than the widths of the confidence intervals that we obtain under iid (θ, g⋆)
optimal sampling scheme.
6.5 Illustrating example.
So far, we have been concerned with results averaged across randomly sampled trajectories and
θ’s ranging over Θ0. Here we present as an illustrating example four trajectories produced by the
iid (θ, gb) and (θ, g⋆) sampling schemes and the adaptive (θ,g⋆n) and (θ,g
a
n) sampling schemes for
θ = (0.2, 0.6) ∈ Θ0.
For each of them, we report the point estimates Ψni(O
1
n7(ni)) of Ψ(θ) = 1.099 at every sample
size ni, as well as the estimated standard deviations s(θ)
2
ni,1, confidence intervals I(θ)ni,1, and
estimates g⋆ni(1) and g
a
ni(1) of the optimal proportion of treated g
⋆(θ)(1) = 0.290 for the two
adaptive procedures — see Table 7.
In addition, we exhibit in Figure 6 several plots illustrating (from left to right) how the se-
quences θn, Ψn, gn, and s(θ)
2
n evolve as the sample size increases when applying the two adaptive
sampling schemes. The most striking feature in the figure, which is representative of all the tra-
jectories we have observed, concerns the adaptive treatment mechanism sequence. Estimating (or
targeting) the optimal treatment mechanism is the driving force of our new adaptive estimation
procedure. It is proven in Theorem 1 that g⋆n(1) and, therefore, the cumulated mean
1
n
∑n
i=1 g
⋆
i (1),
converge to the optimal proportion of treated g⋆(θ)(1) when the sampling scheme is characterized
27
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by (14). We see here that it is the cumulated mean of gan(1) only that converges to g
⋆(θ)(1) when
considering the (θ,gan) sampling scheme.
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Figure 6: Illustrating how the two adaptive (θ,g⋆n), top, and (θ,g
a
n), bottom, sampling schemes
behave as the sample size increases (on x-axis, logarithmic scale; the vertical grey lines indicate
sample sizes ni, i = 1, . . . , 7). From left to right we represent at the same scale over columns the
sequences θn, Ψn = Ψ(θn), g
⋆
n(1) or g
a
n(1) and s(θ)
2
n. Horizontal grey lines indicate the theoretical
limits of the plotted sequences. By convention, θn is initiated at (
1
2 ,
1
2 ) while g
⋆
n(1) and g
a
n(1)
are initiated at 12 . Another convention requires that at least 10 observations are collected before
computing s(θ)2n for the first time, explaining why the corresponding plots start at n = 10 rather
than n = 1. The most striking feature is how smoothly g⋆n(1) converges to g
⋆(θ)(1) when gn = g
⋆
n,
top, as opposed to when gn = g
a
n, bottom.
7 Simulation study of the performances of targeted opti-
mal group sequential testing procedure powered at local
alternatives
In this section, we carry out a simulation study of the performances of targeted optimal design
adaptive procedures in terms of group sequential testing. The three main questions at stake are
“Does the group sequential testing procedure under the targeted optimal design adaptive sampling
scheme guarantee the desired type I error?”, then “Does it guarantee the desired power?”, then
lastly “How well does it compare with the group sequential testing procedure under the targeted
optimal iid sampling scheme?”
We carefully present the simulation scheme in Section 7.1. The section culminates in Section 7.2
with the investigation of the properties of the adaptive group sequential testing procedure in
terms of type I and type II errors. We conclude in Section 7.3 with the simulation study of its
performances in terms of sample sizes at decision.
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7.1 The simulation scheme (continued).
For every θ = (θ0, θ1) ∈ Θ = Θ0 \ {(.1, .7), (.1, .8), (.1, .9), (.2, .8), (.2, .9), (.3, .9)}1, we test M =
1000 times the null “ψ = Ψ(θ)” against the alternative “ψ > Ψ(θ)” with asymptotic type I error
α = 5% and type II error β = 10% at ψ = Ψ(θ) + ∆(θ), where ∆(θ) = Ψ(θ + (0, η)) − Ψ(θ) =
log(1 + η/θ1) (with η = 0.05) is a small increment. Depending on whether we want to investigate
the empirical behaviors of the different testing procedures with respect to type I (i) or type II (ii)
errors, we resort for θ ∈ Θ to
(i) Empirical type I error study:
• iid (θ, gb) balanced sampling,
• iid (θ, g⋆) optimal sampling,
• (θ,g⋆n) adaptive sampling,
• (θ,gan) adaptive sampling,
(ii) Empirical type II error study:
• iid (θ + (0, η), gb) balanced sampling,
• iid (θ + (0, η), g⋆) optimal sampling,
• (θ + (0, η),g⋆n) adaptive sampling,
• (θ + (0, η),gan) adaptive sampling.
We apply a one-sided group sequential testing procedure (as described in Section 5.1) based
on proportions (p1, p2, p3, p4) = (0.25, 0.50, 0.75, 1) and α- and β-spending functions both equal to
t 7→ t2. The designs (values of ∆(θ), maximum committed information Imax, rejection and futility
regions bounds) are reported in Table 8.
θ1 log(1 + η/θ1) Imax(θ1) rejection/futility boundaries
.1 0.405 56.561 (2.734, 2.302, 2.006, 1.716)
(-0.973, 0.136, 0.965, 1.716)
.2 0.223 186.747 (2.734, 2.301, 2.013, 1.720)
(-0.973, 0.138, 0.963, 1.720)
.3 0.154 391.32 (2.734, 2.307, 2.008, 1.716)
(-0.973, 0.135, 0.962, 1.716)
.4 0.118 670.281 (2.734, 2.303, 2.010, 1.718)
(-0.973, 0.145, 0.962, 1.718)
.5 0.095 1023.632 (2.734, 2.298, 2.008, 1.715)
(-0.973, 0.140, 0.961, 1.715)
.6 0.080 1451.372 (2.734, 2.305, 2.006, 1.716)
(-0.973, 0.135, 0.962, 1.716)
.7 0.069 1947.12 (2.734, 2.300, 2.006, 1.715)
(-0.976, 0.133, 0.957, 1.715)
.8 0.061 2530.022 (2.734, 2.306, 2.006, 1.715)
(-0.973, 0.139, 0.961, 1.715)
.9 0.054 3180.931 (2.734, 2.299, 2.006, 1.715)
(-0.973, 0.138, 0.963, 1.715)
Table 8: Description of one-sided sequential testing designs with proportions (p1, p2, p3, p4) =
(0.25, 0.50, 0.75, 1), α- and β-spending functions both equal to t 7→ t2, and asymptotic type I
error α = 5% and type II error β = 10%. Every θ = (θ0, θ1) ∈ Θ is associated with the single
entry corresponding with θ1. For each entry, we provide (with precision 10
−3) the value of the
increment ∆(θ) = log(1 + η/θ1) that yields the parameter ψ1 = Ψ(θ) + ∆(θ) at which the test of
“ψ = Ψ(θ)” against “ψ > Ψ(θ)” is powered, the maximum committed information Imax(θ1), the
rejection region bounds (above) and the futility region bounds (below); note that, of course, the
final rejection and futility bounds coincide.
1Those six values are left aside because it would be computationally demanding to consider them too: for
θ = (θ0, θ1) ∈ Θ0 \ Θ, the key quantities v⋆(θ)Imax(θ1) and vb(θ)Imax(θ1) (which can be interpreted as average
maximal sample sizes at decision) are very large.
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7.2 Empirical type I and type II errors.
Let us consider here the empirical type I and type II errors. We wish to answer the questions
“Does the group sequential testing procedure under the targeted optimal design adaptive sampling
scheme guarantee the desired type I error?” and “Does it guarantee the desired power?”
Testing the empirical type I and type II errors.
Empirical type I errors, that is proportions {a(θ) : θ ∈ Θ}} such thatMa(θ) is the number of times
the null was falsely rejected for its alternative by the testing procedure of “ψ = Ψ(θ)” against
“ψ > Ψ(θ)” powered at ψ = Ψ(θ + (0, η)), are reported in Table 28.
Empirical type II errors, that is proportions {b(θ) : θ ∈ Θ} such that Mb(θ) is the number
of times the null was falsely not rejected for its alternative by the testing procedure “ψ = Ψ(θ)”
against “ψ > Ψ(θ)” powered at ψ = Ψ(θ + (0, η)), are reported in Table 29.
In both tables, the numbers are strikingly close to the wished values (0.05 for Table 28, and
0.9 for Table 29).
Here again we rely on testing to assess rigorously if the requirements on type I and II errors
are met. To this end, we use that the independent rescaled empirical proportions {Ma(θ) : θ ∈ Θ}
should be distributed according to the Binomial distribution with parameter (M,a) with a = α.
This property can be tested in terms of our tailored test, the alternative stating that a > α
(see Section A.3). This results in 4 p-values, as reported in Table 9. Similarly, the independent
rescaled empirical proportions {Mb(θ) : θ ∈ Θ} should be distributed according to the Binomial
distribution with parameter (M, b) = (M, 10%). This property can also be tested in terms of our
tailored test, the alternative stating that b > β = 10% (see Section A.3). This results in 4 p-values,
and we also report them in Table 9. The latter p-values teach us that the study is under-powered.
It remains to assert whether the study is slightly or strongly under-powered: to this end we now
test the null stating that the independent rescaled empirical proportions {Mb(θ) : θ ∈ Θ} are
distributed according to the Binomial distribution with parameter (M, b) = (M, 11%) against the
alternative stating that b > 11%. The corresponding 4 p-values are also reported in Table 9.
sampling scheme type I error type II error (10%) type II error (11%)
iid gb-balanced 0.974 p < 0.001 0.107
iid g⋆-optimal 1.000 0.293 0.180
g⋆n-adaptive 0.552 p < 0.001 0.185
gan-adaptive 0.511 p < 0.001 0.185
Table 9: Checking the adequateness of the type I errors and powers of our simulated targeted
optimal group sequential testing procedures. We test if the rescaled empirical type I errors Bi-
nomial random variables {Ma(θ) : θ ∈ Θ} have parameter (M,α), the alternative stating that
they have parameter (M,a) with a > α and report (in the second column) the obtained p-values
for each sampling scheme. We also test if the rescaled empirical type II errors Binomial random
variables {Mb(θ) : θ ∈ Θ} have parameter (M,β) = (M, 10%) (third column) or (M, 11%), the
alternative stating that they have parameter (M, b) with b > 10% and b > 11% respectively, and
report the obtained p-values for each sampling scheme. The tailored test used here is presented
in Section A.3.
Empirical validation of type I and type II errors.
Considering each sampling scheme (i.e. each row of Table 9) separately, we conclude that
• the type I error control cannot be declared defective for any sampling procedure or, in less
formal terms, that the type I error control is guaranteed for both iid gb-balanced and g⋆-
optimal sampling schemes as well as for both g⋆n-adaptive and g
a
n-adaptive sampling schemes;
• the group sequential testing procedures are all slightly under-powered, in the sense that:
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– the type II error control is declared defective for all sampling schemes (for each of them,
there exists at least one θ ∈ Θ for which the type II error is likely larger than β = 10%);
– however, the type II error control cannot be declared defective for any sampling proce-
dure when substituting β′ = 11% to β = 10% or, in less formal terms, a 11% (rather
than 10%) control of the type II error is guaranteed for both iid gb-balanced and g⋆-
optimal sampling schemes as well as for both g⋆n-adaptive and g
a
n-adaptive sampling
schemes.
This summary notably confirms the conjecture that the Theorem 3 we prove in Section 5.2 for
group sequential testing procedures at deterministic sample sizes still holds for “real-life” group
sequential testing procedures at random sample sizes, as described in Section 5.1.
In conclusion,
Highlight 6 (empirical type I and type II errors). In view of Section 5.1 and Theorem 3, the
(θ,g⋆n) adaptive group sequential testing procedure achieves the desired type I error when testing
against local alternatives. It is slightly underpowered in the sense that the type II error control is
guaranteed at 89% instead of 90% – but the same holds for the iid (θ, g⋆) optimal group sequential
testing procedure.
7.3 Empirical distributions of sample size at decision.
Let us now consider the empirical distributions of sample size at decision, and answer the question
“How well does it compare with the group sequential testing procedure under the targeted optimal
iid sampling scheme?”
Testing the empirical sample size at decision.
We report in Table 30 the mean sample sizes at decision for each θ ∈ Θ when checking the
adequateness of type I error control of our group sequential testing procedures of “ψ = Ψ(θ)”
against “ψ > Ψ(θ)” powered at ψ = Ψ(θ + (0, η)). We also report in Table 31 the mean sample
sizes at decision for each θ ∈ Θ when checking the adequateness of type II error control of our group
sequential testing procedures of “ψ = Ψ(θ)” against “ψ > Ψ(θ)” powered at ψ = Ψ(θ + (0, η)).
Inspecting Tables 30 and 31 tells us, at least in terms of mean sample sizes at decision and
regarding either empirical type I or type II errors, first that the two adaptive group sequential
testing procedures perform as well as the iid g⋆-optimal group sequential testing procedure, and
second that the three latter procedures perform (sometimes, much) better than the iid gb-balanced
group sequential testing procedure when balanced and optimal iid procedures differ. As a summary,
we provide in Table 10 a comparison of mean sample sizes at decision when resorting to iid gb-
balanced group sequential testing procedure with respect to g⋆n-adaptive group sequential testing
procedure. Naturally, the further the percentage is away from the diagonal, the larger is the gain.
Sometimes, the gain is dramatic.
Again, we push further the comparison between empirical distributions of sample size at deci-
sion under each group sequential testing procedure (in the same spirit as the comparison of widths
in Section 6.4). On the one hand, the sample sizes at decision {S(θ, g⋆)m : m = 1, . . . ,M} of the
M independent copies of the iid g⋆-optimal group sequential testing procedure provides us with
an empirical counterpart of a benchmark distribution of optimal sample size at decision. On the
other hand, we also have at hand the empirical distributions of sample sizes at decision obtained
under iid gb-balanced and both g⋆n-adaptive and g
a
n-adaptive group sequential testing procedures
which we see as empirical counterparts of distributions that we would like to compare to the
aforementioned benchmark distribution.
Regarding the comparison of the iid group sequential testing procedures, we propose to test
across Θ, in terms of our tailored test for comparison of sample sizes at decision (see Section A.4), if
the distribution of sample size at decision under iid gb-balanced group sequential testing procedure
rescaled by a factor R(θ) coincides with the benchmark distribution (null), rather than being
stochastically smaller (alternative hypothesis). This yields a p-value smaller than 10−6. In other
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θ .1 .2 .3 .4 .5 .6 .7 .8 .9
.1 1% 6% 10% 14% 26% 31% - - -
.2 - 2% 1% 5% 12% 18% 24% - -
.3 - - 2% 0% 6% 9% 16% 24% -
.4 - - - 1% 2% 2% 11% 17% 33%
.5 - - - - 1% -1% 6% 11% 26%
.6 - - - - - 2% 1% 3% 13%
.7 - - - - - - -2% 3% 12%
.8 - - - - - - - 3% 4%
.9 - - - - - - - - 6%
gains when evaluating empirical type I error
θ .1 .2 .3 .4 .5 .6 .7 .8 .9
.1 2% 6% 19% 21% 32% 36% - - -
.2 - 0% 4% 8% 14% 21% 30% - -
.3 - - -4% 2% 9% 13% 22% 33% -
.4 - - - 0% 2% 5% 13% 27% 53%
.5 - - - - 0 2% 10% 19% 41%
.6 - - - - - 1% 3% 11% 29%
.7 - - - - - - 3% 4% 30%
.8 - - - - - - - 3% 21%
.9 - - - - - - - - 10%
gains when evaluating empirical type II error
Table 10: Comparing mean sample sizes at decision when resorting to iid gb-balanced group
sequential testing procedure with respect to g⋆n-adaptive group sequential testing procedure. The
top table corresponds to Table 30 and evaluation of empirical type I error, while the bottom
table to Table 31 and evaluation of empirical type II error. Entries are of the form (S¯(θ, gb) −
S¯(θ,g⋆n))/S¯(θ,g
⋆
n), where S¯(θ, g
b) (respectively, S¯(θ, gb)) denotes the empirical mean sample size
at decision under iid gb-balanced sampling (respectively, g⋆n-adaptive sampling).
words, we can conclude that there exists some θ ∈ Θ for which the sample size at decision under iid
g⋆-optimal group sequential testing is stochastically larger than the corresponding R(θ)-rescaled
sample size at decision under iid gb-balanced group sequential testing. However, we can slightly
adapt the procedure we just presented, rescaling more modestly by a sub-optimal factor. We
compare now, in the same terms and with the same benchmark distribution, the distribution of
sample size at decision under iid gb-balanced group sequential testing procedure rescaled by a factor
R(θ)ρ for the arbitrarily chosen ρ = 0.45. The two p-values thus obtained are reported in Table 11.
Regarding the comparison of the g⋆n-adaptive and g
a
n-adaptive group sequential testing procedures
to the iid g⋆-optimal group sequential testing procedure, we propose to test across Θ, in terms of
our tailored test for comparison of sample sizes at decision (see Section A.4), if the distributions
of sample size at decision under either adaptive group sequential testing procedures coincides with
the benchmark distribution (null), rather than being stochastically larger (alternative hypothesis).
This yields 4 p-values (two when investigating the behaviors with respect to type I error, two with
respect to type II error) that we report in Table 11.
Empirical validation of sample sizes at decision.
Considering each sample scheme (i.e. each row of the table) separately, we conclude that
• the sample sizes at decision obtained under iid (θ, gb) balanced group sequential testing and
rescaled by the corresponding factor R(θ)ρ (ρ = 0.45) are not stochastically smaller than
the sample sizes at decision obtained under iid (θ, g⋆) optimal group sequential testing;
• the sample sizes at decision obtained under iid (θ + (0, η), gb) balanced group sequential
testing procedure and rescaled by the corresponding factor R(θ+ (0, η))ρ (ρ = 0.45) are not
stochastically smaller than the sample sizes at decision obtained under iid (θ + (0, η), g⋆)
optimal group sequential testing procedure;
• the sample sizes at decision obtained under both (θ,g⋆n) and (θ,gan) adaptive group sequential
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sampling scheme type I error type II error
iid gb-balanced 0.625 0.727
g⋆n-adaptive 0.994 1.000
gan-adaptive 0.898 0.949
Table 11: Comparing across Θ the empirical distributions of sample sizes at decision. First row:
We report p-values derived when comparing, across Θ, the empirical distributions of rescaled sam-
ple sizes at decision (by a factor R(θ)ρ with ρ = 0.45) under iid gb-balanced sampling to the
empirical counterpart of the benchmark distributions of sample sizes at decision obtained under
iid g⋆-optimal sampling, in terms of our tailored test for comparison of sample sizes at decision
(see Section A.4), the alternative hypothesis stating that the latter are stochastically larger than
the former. Second and third rows: We report p-values derived when comparing, across Θ, the
empirical distributions of sample sizes at decision obtained under g⋆n-adaptive sampling (second
row), or under gan-adaptive sampling (third row), to the empirical counterpart of the benchmark
distributions of sample sizes at decision obtained under iid g⋆-optimal sampling, in terms of our
tailored test for comparison of sample sizes at decision (see Section A.4), the alternative hypoth-
esis stating in both case that the latter are stochastically smaller than the former distributions.
The second column corresponds to data gathered when investigating the behaviors of the group
sequential testing procedures in terms of type I error, the third column corresponding to the same
investigation but in terms of type II error.
testing procedures are not stochastically larger than the sample sizes at decision obtained
under iid (θ, g⋆) optimal group sequential testing procedure;
• the sample sizes at decision obtained under both (θ+(0, η),g⋆n) and (θ+(0, η),gan) adaptive
group sequential testing procedures are not stochastically larger than the sample sizes at
decision obtained under iid (θ + (0, η), g⋆) optimal group sequential testing procedure.
Overall, the main message stated in less formal terms is that both adaptive group sequential
testing procedures perform as well as the optimal iid group sequential testing procedure with
respect to sample size at decision, either under the null or under the alternative.
Highlight 7 (empirical sample sizes at decision). In view of Section 5.1 and Theorem 3, the (θ,g⋆n)
adaptive group sequential testing procedure behaves as the iid (θ, g⋆) optimal group sequential testing
procedure in terms of sample sizes at decision, both under the null and under local alternatives.
8 Discussion
We have studied in this article the properties of a new adaptive group sequential design method-
ology for randomized clinical trials with binary treatment, binary outcome and no covariate (the
experimental unit writes as O = (A, Y ) ∈ {0, 1}2, A being the assigned treatment and Y the
corresponding outcome).
Prior to accruing data, the trial protocol must specify Ψ, the parameter of interest. Regarding
the estimation of Ψ, the trial protocol must specify the confidence level to be used in constructing
the confidence interval. Regarding the testing of Ψ, the trial protocol must specify the null and
alternative hypotheses, the wished type I error, the alternative parameter at which the test is to
be powered and the related wished type II error. If the investigator wants to resort to a group
sequential testing procedure, then the trial protocol must also specify the number of intermediate
tests, the related proportions, the α- and β-spending strategies (then the maximum committed
information, rejection and futility boundaries are fully determined). Finally, the trial protocol
must specify the (fixed) targeted design. We decided to focus in this article on the log-relative
risk Ψ = logE(Y |A = 1)− logE(Y |A = 0) and on that design g⋆ which minimizes the asymptotic
variance of the maximum likelihood estimator of Ψ. Other choices can be treated likewise.
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The methodology is adaptive in the sense that the estimator of g⋆, which appears to be strongly
consistent (see Highlight 1), is alternatively used in the process of accruing new data, then updated
and so on. The resulting maximum likelihood estimator of Ψ, Ψn, is strongly consistent (see
Highlight 1). It satisfies a central limit theorem, and performs as well (in terms of asymptotic
variance) as its counterpart under iid sampling using g⋆ itself (see Highlight 1). Therefore, one
easily constructs confidence intervals which are as narrow as the intervals one would get, has one
known in advance g⋆ and used it to sample independently data (see Highlight 1). Those theoretical
results are validated with simulations. Notably, a test across a large collection of data-generating
distributions indexed by Θ shows that the limiting Gaussian law is empirically reached by the
sequence of laws of
√
n(Ψn − Ψ) as soon as 500 observations are collected. This is as good as
what one would get, has one known in advance g⋆ and used it to sample independently data (see
Highlight 3). Most importantly, another test across Θ reveals that the wished coverage is achieved
as soon as 500 observations are collected. In contrast, a sample size of 100 observations would
suffice, has one known in advance g⋆ and used it to sample independently data (see Highlight 4).
This is the price to pay for adapting. In conclusion, yet another test across Θ shows that, whenever
the sample size exceeds 100, the widths of confidence intervals obtained under adaptive sampling
schemes are not significantly greater than the widths of the intervals one would get, has one known
in advance g⋆ and used it to sample independently data (see Highlight 5).
Furthermore, we explain how a group sequential testing procedure can be equally well applied
on top of the adaptive sampling methodology (see Highlight 2). An accompanying theoretical
result validates the adaptive group sequential testing procedure in the context of contiguous null
and alternative hypotheses. It is supported by simulations. Most importantly, a test across a large
collection of pairs of null and local alternative hypotheses indexed by Θ′ demonstrates that the
adaptive group sequential testing procedure achieves the desired type I error (see Highlight 6).
Moreover, a complementary test across Θ′ reveals that the adaptive group sequential testing
procedure is very slightly under-powered. Interestingly, has one known in advance g⋆ and used it
to sample independently data, the resulting group sequential testing procedure would suffer from
the same minor lack of power (see Highlight 6). Finally, a last test across Θ′ shows that the laws
of sample sizes at decision under adaptive group sequential testing procedure do not significantly
differ from the laws of sample sizes at decision that one would get, has one known in advance g⋆
and used it to sample independently data and apply the iid group sequential testing procedure
(see Highlight 7).
As stated in the abstract, a three-sentence take-home message is “Adaptive designs do learn
the targeted optimal design and inference and testing can be carried out under adaptive sampling
as they would under the targeted optimal randomization probability iid sampling. In particular,
adaptive designs achieve the same efficiency as the fixed oracle design. This is confirmed by a
simulation study, at least for moderate or large sample sizes, across a large collection of targeted
randomization probabilities.” In essence, everything works as predicted by theory. However,
theory also warns us that gains cannot be dramatic in the particular setting of clinical trials
with binary treatment, binary outcome and no covariate. Nonetheless, this article is important:
it provides a theoretical template and tools for asymptotic analysis of robust adaptive designs
in less constrained settings, which we will consider in future work. This notably includes the
setting of clinical trials with covariate, binary treatment, and discrete or continuous outcome, or
the setting of clinical trials with covariate, binary treatment, and possibly censored time-to-event
among others. Resorting to targeted maximum likelihood estimation [27] along with adaptation
of the design provides substantial gains in efficiency.
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A Appendix
Normalized martingale sums of the formMn(f) =
1
n
∑n
i=1[f(Oi, Zi)−Pθ,gif ] with Zi = Zi(On(i−
1)) play a central role in this study. The Kolmogorov strong law of large numbers (see e.g.
Theorem 2.4.2 in [24]) guarantees that Mn(f) converges in probability to 0 almost surely for
any uniformly bounded function f . However, in order to get consistency results, we need a
uniform convergence result for supf∈F |Mn(f)| for a certain class F . This issue is addressed in
A.1. Similarly, in order to get a central limit theorem, we need the convergence of
√
nMn(f) to
a Gaussian random variable. We derive this result in Section A.2 from a standard central limit
theorem for discrete martingales (see e.g. Theorem 3.3.7 in [24]).
Sections A.3 and A.4 are dedicated to the description of the tailored tests used throughout the
simulation study of Sections 6 and 7. The latter tests provide single p-values for multiple pairwise
comparisons in the context of our simulations, notably dealing with the multiplicity of elementary
tests carried out.
Finally additional tables are gathered in Section A.5.
A.1 Building block for consistency results.
Let On be a sequence of successive observations obtained as described in Section 3. We denote
by Zi = Zi(On(i − 1)) ∈ Z ⊂ Rd a summary measure of On(i − 1) of fixed dimension d (for
instance Zi = θi−1 ∈ R2, the current maximum likelihood estimator of θ at step i). Let F be a
class of bounded (and measurable) functions of (o, z) = (a, y, z) such that supf∈F ‖f‖∞ = U <∞
(for instance, f(Oi, Zi) = D(ϑ)(Oi) − Pθ,g⋆
i
D(ϑ) for some ϑ ∈ [0, 1]2, where the dependency wrt
Zi = θi−1 is conveyed through g⋆i ). Defining
Mn(f) =
1
n
n∑
i=1
[f(Oi, Zi)− Pθ,gif ]
for all f ∈ F and n ≥ 1, we note that nMn(f) is a discrete martingale sum.
Our uniform convergence result, Theorem 8, essentially relies on a maximal inequality for
martingales taken from [30] (Proposition A.2) which we now present.
Let φ be the function characterized over R by φ(x) = ex − x − 1. We define the generalized
entropy with bracketing as follows. Let n ≥ 1, K > 0 and ε > 0 be given. A finite collection
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{(Λji ,Υji )i≤n}j≤N of random variables is called a (n,F ,K, ε)-bracketing set if Λji and Υji are
(measurable) functions of On(i) for all i ≤ n, j ≤ N and if for every f ∈ F , there exists j ≤ N
(the map f 7→ j is non-random) such that P -almost surely, for all i ≤ n,
Λji ≤ f(Oi, Zi) ≤ Υji
and such that, for all j ≤ N ,
2K2
n
n∑
i=1
E
[
φ
(
|Υji − Λji |
K
)∣∣∣∣∣On(i− 1)
]
≤ ε2.
We denote by N(n,F ,K, ε) the cardinality N of the smallest (n,F ,K, ε)-bracketing set, and call
H(n,F ,K, ε) = logN(n,F ,K, ε) its generalized entropy with bracketing. Then,
Theorem 6 (Proposition A.2 in [30]). Fix K > 0 and define
Rn,K(f) =
2K2
n
n∑
i=1
Pθ,giφ
( |f |
K
)
for all f ∈ F and n ≥ 1. There exists a universal constant C > 0 (the choice C = 100 works)
such that, for any n ≥ 1, R > 0,
P
(
sup
f∈F
1l{Rn,K(f) ≤ R}max
i≤n
i
n
Mi(f) ≥ α
)
≤ 2 exp
{
− nα
2
C2(c1 + 1)R
}
for any α, c0, c1 > 0 satisfying c
2
0 ≥ C2(c1 + 1) and
c0√
n
∫ √R
0
√
H(n,F ,K, x)dx ≤ α ≤ c1R
K
. (27)
Note that the uncountable supremum is interpreted as an essential supremum under P , in
order to avoid measurability issues.
It appears that it is important to understand the behavior of the random variables Rn,K(f)
for f ∈ F . Furthermore, condition (27) may be hard to check because of the relatively intricate
definition of the generalized entropy with bracketing. The following lemma provides answers to
both issues. Notably, H(n,F ,K, ε) is here easily related to the standard entropy for the supremum
norm H(F , ‖ · ‖∞, ε) = logN(F , ‖ · ‖∞, ε). Recall that N(F , ‖ · ‖∞, ε) is the cardinality of the
smallest finite collection (ℓj , uj)j≤N , where ℓj ≤ uj are (measurable) functions of (o, z) = (a, y, z)
satisfying ‖uj − ℓj‖∞ ≤ ε for all j ≤ N , such that for every f ∈ F , there exists j ≤ N for which
ℓj ≤ f ≤ uj.
Lemma 7. Recall that supf∈F ‖f‖∞ = U <∞. It holds that:
(i) For all n ≥ 1 and f ∈ F , Rn,4U (f) ≤ 43U2.
(ii) For all n ≥ 1 and ε > 0, H(n,F , 4U,√2ε) ≤ H(F , ‖ · ‖∞, ε).
Proof. First, arbitrarily choose f ∈ F . For each i ≤ n and all m ≥ 2, since ‖f‖∞ ≤ U , one has
Pθ,gi |f |m ≤ Um ≤ m!2 Um, hence
2(4U)2Pθ,giφ
( |f |
2U
)
= 32U2
∑
m≥2
Pθ,gi |f |m
m!(4U)m
≤ 16U2
∑
m≥2
4−m =
4
3
U2.
This straightforwardly entails (i).
Second, fix ε > 0, define N = exp{H(F , ‖ · ‖∞, ε)} and let the collection (ℓj, uj)j≤N satisfying
‖uj − ℓj‖∞ ≤ ε for all j ≤ N , be such that for every f ∈ F , there exists j ≤ N for which
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ℓj ≤ f ≤ uj . Introduce Λji = ℓj(Oi, Zi) ∧ (−U) and Υji = uj(Oi, Zi) ∨ U for every i ≤ n, j ≤ N .
For each f ∈ F , there exists j ≤ N (the map f 7→ j is non-random) such that −U ≤ Λji ≤
f(Oi, Zi) ≤ Υji ≤ U for all i ≤ n.
Set j ≤ N . For each i ≤ n and all m ≥ 2, one has E[|Υji − Λji |m|On(i − 1)] ≤ (2U)m−2ε2 ≤
m!
2 (2U)
m−2ε2, hence
2(4U)2E
[
φ
(
|Υji − Λji |
4U
)∣∣∣∣∣On(i− 1)
]
= 32U2
∑
m≥2
E[|Υji − Λji |m|On(i− 1)]
m!(4U)m
≤ 2ε2.
Property (ii) immediately follows.
Now we can state and prove our building block for consistency results:
Theorem 8. Recall that supf∈F ‖f‖∞ = U < ∞. If
∫√2/3U
0
√
H(F , ‖ · ‖∞, x)dx < ∞ then for
all α > 0 there exists c > 0 such that, for n large enough,
P
(
sup
f∈F
Mn(f) ≥ α
)
≤ 2e−nc.
Consequently, supf∈F |Mn(f)| converges to 0 almost surely.
Proof. Fix α > 0 and choose K = 4U , R = 43U
2, c1 =
αK
R , c0 = C
√
c1 + 1 (C is the uni-
versal constant introduced in Theorem 6) and let n1 be the smallest integer such that
√
n ≥
c0
α
∫√R/2
0
√
H(F , ‖ · ‖∞, x)dx. Note that (ii) in Lemma 7 guarantees that condition (27) from
Theorem 8 is met, while condition (i) of the same lemma implies that 1l{Rn,K(f) ≤ R} = 1.
Therefore, Theorem 8 ensures that, for all n ≥ n1,
P
(
sup
f∈F
Mn(f) ≥ α
)
≤ P
(
sup
f∈F
max
i≤n
i
n
Mi(f) ≥ α
)
≤ 2e−nc,
where c = α2/c20R.
Now one can assume without loss of generality that for each f ∈ F , −f ∈ F too (otherwise,
define F ′ = F ∪ {−f : f ∈ F} and note that supf∈F ′ ‖f‖∞ = U and N(F ′, ‖ · ‖∞, ε) ≤ 2N(F , ‖ ·
‖∞, ε) for all ε > 0). Obviously then, supf∈F |Mn(f)| = max{supf∈FMn(f), supf∈FMn(−f)} =
supf∈FMn(f). We conclude by virtue of the Borel-Cantelli lemma.
A.2 Building block for central limit theorems.
First, we obtain a central limit theorem for univariate discrete martingale sums as a by-product
of a classical theorem (see e.g. Theorem 3.3.7 in [24]). Second, we rely on it and invoke the
Crame´r-Wold device (see e.g. Theorem 3.2.4 in [24]) in order to extend the result to the case of
multivariate discrete martingale sums.
Univariate case.
We use the same framework and notation as those exposed at the beginning of Section A.1. For
a given real-valued f ∈ F , let us introduce
wn(f)
2 =
n∑
i=1
Pθ,gif
2,
sn(f)
2 = Ewn(f)
2 =
n∑
i=1
Ef(Oi, Zi)
2, and
σn(f)
2 =
sn(f)
2
n
.
The following univariate central limit theorem holds:
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Theorem 9. Assume that for all i = 1, . . . , n, gi(Ai|An(i − 1),Xn) = gi(Ai|Xi(Ai),On(i −
1)) (by virtue of the adaptive CAR assumption (9)) only depends on On(i − 1) through Zi. If
lim inf σn(f)
2 > 0 and 1nwn(f)
2 − 1nEwn(f)2 = 1nwn(f)2 − σn(f)2 converges in probability to 0,
then wn(f)
2/sn(f)
2 converges to 1 in probability and
√
nMn(f)σn(f) converges in distribution to the
standard normal distribution.
Furthermore, the empirical mean σˆn(f)
2 = 1n
∑n
i=1 f(Oi, Zi)
2 mimics σn(f)
2 in the sense that
σˆn(f)
2−σn(f)2 converges to 0 in probability. Consequently,
√
nMn(f)σˆn(f) also converges in distribution
to the standard normal distribution.
This result notably teaches us that we can estimate the asymptotic variance of
√
nMn(f) by
considering O1, . . . , On as independent draws from Pθ,gi , treating each gi as a given deterministic
fixed design in G. Therefore, the parametric or non-parametric bootstrap ignoring the dependence
structure of On consistently estimate the limiting variance.
Proof. Regarding the behavior of σˆn(f)
2, note that
σˆn(f)
2 = σn(f)
2 +
(
1
n
wn(f)
2 − σn(f)2
)
+
1
n
M ′n = σn(f)
2 +
1
n
M ′n + oP (1)
where M ′n =
∑n
i=1(f(Oi, Zi)
2 − Pθ,gif2) is a discrete martingale sum with uniformly bounded
terms. The Kolmogorov strong law of large numbers (see e.g. Theorem 2.4.2 in [24]) guarantees
that 1nM
′
n converges almost surely, hence in probability, to 0. So σˆn(f)
2 − σn(f)2 = oP (1)
and, by Slutsky’s lemma,
√
nMn(f)/σˆn(f) converges to a standard normal distribution when√
nMn(f)/σn(f) does.
To prove this, we invoke the central limit theorem for discrete martingales (see e.g. Theo-
rem 3.3.7 in [24]). First, we must check that wn(f)
2/sn(f)
2 converges to 1 in probability. Now,
since lim inf σn(f)
2 > 0, there exist n1 ≥ 1, C > 0 such that n ≥ n1 yields σn(f)2 ≥ C and also∣∣∣∣wn(f)2sn(f)2 − 1
∣∣∣∣ =
∣∣ 1
nwn(f)
2 − σn(f)2
∣∣
σn(f)2
≤ 1
C
∣∣∣∣ 1nwn(f)2 − σn(f)2
∣∣∣∣ = oP (1)
by assumption. Second, we must check that for every ε > 0,
n∑
i=1
E
(
f(Oi, Zi)
21l{f(Oi, Zi)2 ≥ ε2sn(f)2}
)
= o(sn(f)
2). (28)
Fix ε > 0 and n > max{n1, ‖f‖2∞/ε2C}: 1l{f(Oi, Zi)2 ≥ ε2sn(f)2} ≤ 1l{‖f‖2∞ ≥ nε2C} = 0,
so that the left-hand side expression in (28) is bounded while sn(f)
2 goes to infinity. Therefore,
the central limit theorem for discrete martingales applies, and implies that
√
nMn(f)σn(f) converges in
distribution to the standard normal distribution. This concludes the proof.
Multivariate case.
Let us state the multivariate version of Theorem 9. It involves the following multidimensional
counterparts of wn(f)
2, sn(f)
2 and σn(f)
2 in the case that f ∈ F takes values in Rr (expectations
are taken componentwise):
Wn(f) =
n∑
i=1
Pθ,giff
⊤,
Sn(f) = EWn(f) =
n∑
i=1
Ef(Oi, Zi)f(Oi, Zi)
⊤, and
Σn(f) =
Sn(f)
n
.
For every positive definite symmetric matrix Σ, we denote by Σ−1/2 the positive definite
symmetric matrix such that (Σ−1/2)2 is the inverse of Σ.
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Theorem 10. Assume that for all i = 1, . . . , n, gi(Ai|An(i− 1),Xn) = gi(Ai|Xi(Ai),On(i− 1))
(by virtue of the adaptive CAR assumption (9)) only depends on On(i− 1) through Zi. If Σn(f)
converges to a positive definite covariance matrix Σ(f) and 1nWn(f) − 1nEWn(f) = 1nWn(f) −
Σn(f) converges componentwise in probability to 0, then
√
nMn(f) converges in distribution to
the centered Gaussian law over Rr with covariance matrix Σ(f).
Furthermore, the empirical mean Σˆn(f) =
1
n
∑n
i=1 f(Oi, Zi)f(Oi, Zi)
⊤ is such that Σˆn(f) con-
verges to Σ(f) in probability. Consequently, Σˆn(f) is invertible with probability tending to 1 as
n tends to infinity, and
√
nΣˆn(f)
−1/2Mn(f) converges in distribution to the standard normal
distribution over Rr.
Proof. The Crame´r-Wold device (see e.g. Theorem 3.2.4 in [24]) teaches us that
√
nMn(f) con-
verges in distribution to the centered Gaussian law over Rr with covariance matrix Σ(f) if and
only if
√
nλ⊤Mn(f) converges to the centered Gaussian distribution over R with variance λ⊤Σ(f)λ
for all λ ∈ Rr. Arbitrarily choose λ ∈ Rr and consider λ⊤Mn(f) = Mn(λ⊤f). Does Theorem 9
apply?
Note first that σn(λ
⊤f)2 = λ⊤Σn(f)λ and also that 1nwn(λ
⊤f)2 − σn(λ⊤f)2 = λ⊤( 1nWn(f)−
Σn(f))λ. Therefore lim inf σn(λ
⊤f)2 = limσn(λ⊤f)2 = λ⊤Σ(f)λ > 0, 1nwn(λ
⊤f)2 − σn(λ⊤f)2
converges to 0 in probability, Theorem 9 applies and yields that
√
nλ⊤Mn(f) converges to the
desired Gaussian distribution, hence the stated convergence of
√
nMn(f).
Following the same lines as in the proof of Theorem 9, we then remark that
Σˆn(f) = Σn(f) +
(
1
n
Wn(f)− Σn(f)
)
+
1
n
M ′n = Σ(f) +
1
n
M ′n + oP (1),
where M ′n =
∑n
i=1(ff
⊤(Oi, Zi) − Pθ,giff⊤) is a discrete (multivariate) martingale sum with
uniformly bounded terms. The Kolmogorov-Smirnov strong law of large numbers (see eg Theo-
rem 2.4.2 in [24]) guarantees that 1nM
′
n converges almost surely, hence in probability, to 0. The rest
follows because the set of invertible symmetric matrices is open in the set of symmetric matrices,
and thanks to Slutsky’s lemma.
A.3 A tailored test of empirical coverage, type I error and power.
Many times in this article we wish to test if the requirements on confidence intervals coverage,
type I error and power of tests are met across several data generating distributions (characterized
by Θ0 or a subset Θ of it). Those three issues can be addressed in a common simple framework.
Single p-value for multiple pairwise comparisons.
In each case, the decision must be made based on iid Binomial random variables {B(θ) : θ ∈ Θ}
with parameters (M,p), the null stating “p = π” and its alternative “p < π” (when testing the
empirical coverage and power) or “p > π” (when testing the empirical type I error).
Let us denote by Fp the Binomial cdf with parameters (M,p). Every B(θ) is associated with
a p-value P (θ) which is either Fπ(B(θ)) (when testing the empirical coverage and power) or
(1 − Fπ(B(θ))) (when testing the empirical type I error). Rather than using the latter p-values
directly, we consider the randomly perturbed P ′(θ) = P (θ) + εU(θ), for iid Uniform random
variables {U(θ) : θ ∈ Θ} over [0, 1] and a small real number ε > 0. The substitution of P ′(θ) to
P (θ) is advantageous because the distribution Gp,ε of P
′(θ) is continuous, whereas that of P (θ) is
not (and we do observe several ties in every situation). In addition, P ′(θ) is stochastically smaller
under the alternative than under the null: Gπ,ε ≤ Gp,ε, small values of P ′(θ) therefore being more
likely under the alternative than under the null.
The final step consists of comparing the empirical distribution of {P ′(θ) : θ ∈ Θ} with Gπ,ε.
We decide to do so in terms of one-sided Kolmogorov-Smirnov goodness-of-fit, the alternative
stating that the common cdf of the P ′(θ)’s lies above Gπ,ε. We estimate Gπ,ε by its empirical
counterpart based on 106 simulated random variables drawn from Gπ,ε. This procedure yields a
single p-value Πp,ε whose distribution under the null “p = π” is uniform over [0, 1].
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Simulation study.
The tailored procedure we just described inherits a great sensibility to departures from the null
from that of the Kolmogorov-Smirnov goodness-of-fit test. This is the obvious conclusion drawn
from the study of Figure 7. We reproduce by simulation the behavior of the p-value Πp,ε of our
procedure in the context of empirical coverage, type I error and power quality assessment. By
symmetry, it is equivalent to evaluate the performance of our procedure for testing 95%-coverage
and 5%-type I error quality assessment. We simulate 1000 independent copies of a collection of
45 (the cardinality of Θ0) iid Binomial random variables with parameter (M,p), p ranging
• from π = 0.050 (correct type I error) to 0.055 (inflated type I error),
• from π = 0.900 (correct power at alternative) to 0.895 (deflated power at alternative)
by steps of length 10−3. The constant ε is arbitrarily set to 10−6. Based on those simulated
datasets, we can estimate accurately the cdf u 7→ Pp(Πp,ε ≤ u) of Πp,ε in each configuration. The
fit to a Uniform distribution over [0, 1] under the two nulls is perfect. In addition, the procedure
features large power at local alternatives.
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Figure 7: Illustrating the sensibility of our tailored test of empirical coverage, type I error and
power. Left: estimated cdf u 7→ Pˆp=a(Πp,ε ≤ u) for a = 0.050 (rightmost curve) to a = 0.055
(leftmost curve). Right: estimated cdf u 7→ Pˆp=1−b(Πp,ε ≤ u) for b = 0.100 (rightmost curve) to
c = 0.105 (leftmost curve). The two plots share the same range on x-axis (in logarithmic scale)
and y-axis. A vertical and an horizontal lines at the reference level α = 5% are drawn on each
plot.
A.4 A tailored test for multiple pairwise comparisons of empirical dis-
tributions of confidence interval widths or sample sizes at decision.
In the same spirit as in the previous section, we want to come up with a common framework
to compare two empirical distributions of confidence interval widths or sample sizes at decision
across several data generating distributions (characterized again by Θ0 or a subset of it). Some
extra care is needed because the distribution of sample size at decision has atoms.
Single p-value for pairwise comparison.
Denote by PF and PF ′ two probability distributions over the real line, with respective cdf’s F and
F ′ that may have jumps. We want to test the null “F = F ′” against the alternative “∃ t ∈ R :
F ′(t) < F (t)”. The test is based on two independent n-tuples of iid random variables O1, . . . , On ∼
PF and O
′
1, . . . , O
′
n ∼ PF ′ . We decide to rely on the two-sample one-sided Kolmogorov-Smirnov
statistic Tn: letting Pn = n
−1∑n
i=1 δOi and P
′
n = n
−1∑n
i=1 δO′i be the empirical distributions and
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F = {1l(−∞, t] : t ∈ R}, Tn =
√
n/2 supf∈F [(Pn − P′n)f ], the rescaled maximum gap between the
empirical counterparts of F and F ′ over the set of those points where the former dominates the
latter. The following lemma is a well-known result (see Chapter 19 of [28] and pages 85 and 142
of [5]):
Lemma 11. Under the null, Tn supf∈F GF f where the PF -Brownian bridge GF is the zero
mean Gaussian process over F characterized by the covariance structure EGF fGFg = PF fg −
PF fPFg for every f, g ∈ F . Under the alternative, Tn tends to infinity almost surely. In addition,
if F is continuous, then P(supf∈F GF f ≥ t) = e−2t
2
for all t ≥ 0.
This result suggests to reject the null when the observed value of the test statistic Tn is
larger than the upper α-quantile of its limit distribution under the null. The asymptotic p-
value Pn = P(supf∈F GF f ≥ t)|t=Tn is known in closed form when F is continuous (for instance
when comparing distributions of confidence intervals widths): Pn = e
−2T 2
n , but not otherwise (for
instance when comparing distributions of sample size at decision). However, it is possible to resort
to the bootstrap to estimate Pn when F is not continuous.
Define Fn =
1
2 (Pn+P
′
n), the pooled empirical measure. Let O
∗
1 , . . . , O
∗
n and O
′∗
1 , . . . , O
′∗
n be two
independent iid samples from Fn. They give rise to the bootstrapped empirical distributions Pˆn =
n−1
∑n
i=1 δO∗i and Pˆ
′
n = n
−1∑n
i=1 δO′∗
i
, and to the bootstrapped empirical process Gˆn =
√
n(Pˆn−
Pˆ′n), hence finally to Tˆn =
√
n/2 supf∈F Gˆnf =
√
n/2 supf∈F [(Pˆn − Pˆ′n)f ]. The next lemma
teaches us that the conditional distribution of Tˆn consistently estimates the limit distribution
of Tn under the null (see Chapter 2.9 of [29] for the definition of conditional convergence in
distribution; the lemma is a straightforward application of Theorem 3.6.2 in [29]):
Lemma 12. Tˆn supf∈F GF f given almost every sequence O1, O2, . . . , O
′
1, O
′
2, . . ..
Consequently, it is possible to estimate Pn when F is not continuous by generating a large
number B of independent copies Tˆ bn of Tˆn and using Pn ≃ B−1
∑B
b=1 1l{Tˆ bn ≥ Tn}.
Single p-value for multiple pairwise comparisons.
Say that each θ ∈ Θ comes with the empirical counterparts of two distributions PF (θ),PF ′(θ)
and that we wish to test the global null “∀ θ ∈ Θ, F (θ) = F ′(θ)” against the alternative “∃ θ ∈
Θ, ∃ t ∈ R : F ′(θ)(t) < F (θ)(t)”. Here PF (θ) may for instance be the distribution of the width of a
confidence interval for the log-relative risk obtained under iid optimal (θ, g⋆) sampling and PF ′(θ)
that of a confidence interval for the same parameter obtained under adaptive (θ,g⋆n) sampling for
a given sample size ni, see Section 6. Or PF (θ) may the distribution of sample size at decision for
sequential testing of a certain couple of hypotheses under iid optimal (θ, g⋆) sampling and PF ′(θ)
that of sample size at decision for sequential testing of the same hypotheses under adaptive (θ,g⋆n)
sampling, see Section 7.
We just showed how to associate a p-value P (θ) with each θ while testing “F (θ) = F ′(θ)”
against “∃ t ∈ R : F ′(θ)(t) < F (θ)(t)”. Under the so-called global null hypothesis, the independent
p-values {P (θ) : θ ∈ Θ} are uniformly distributed over [0, 1]. Under its alternative, at least one
of them is more likely to take smaller values than a Uniform random variable. Proceeding as in
Section A.3, assuming in particular that the p-values are identically distributed (even when the
global null does not hold, a reasonable assumption in our context), we finally test the global null
against its alternative in terms of one-sided Kolmogorov-Smirnov goodness-of-fit test: we compare
the empirical distribution of {P (θ)+ εU(θ) : θ ∈ Θ0} for arbitrarily fixed small real number ε > 0
and iid Uniform random variables {U(θ) : θ ∈ Θ} with the Uniform distribution over [0, 1] (we
neglect the impact of the ε times Uniform random variable terms), the alternative stating that
the common cdf of the P (θ)’s lies above that of the Uniform distribution. Finally, we decide to
reject the global null for its alternative if the latter Kolmogorov-Smirnov test yields a rejection of
its null hypothesis.
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Simulation study.
In order to illustrate the tailored procedure for multiple pairwise comparisons of empirical distri-
butions of sample sizes at decision that we just described, we propose to carry out the following
simulation study.
In the first place, let us present objective of the simulation study. Say that we first retrieve
the #Θ independent samples {S(θ, g⋆)m : m = 1, . . . ,M} (for each θ ∈ Θ) of sample sizes at
decision obtained while testing “ψ = Ψ(θ)” against “ψ > Ψ(θ)” in the framework of Section 7.2
and the simulation study of type I error. Let us denote by PM (θ) the empirical distribution of
S(θ, g⋆)1, . . . , S(θ, g
⋆)M . For each θ ∈ Θ, we draw two independent random samples of length
1000 from PM (θ): the first one is considered as a reference sample, while the second one is
(deterministically) perturbed in order to yield a second sample whose distribution is either the
same as the distribution of the reference sample or dominated by the distribution of the reference
sample (i.e. values from the second sample tend to be larger than values from the first sample).
Therefore we obtain two independent collections of #Θ independent random samples of same
lengths. We then resort to our tailored procedure for multiple pairwise comparisons of empirical
distributions of sample sizes in order to compare them, yielding a p-value Πp,ε (where p indicates
how we perturb the second sample and ε is the arbitrarily fixed small real number used in the
testing procedure). The objective of the simulation study that we are on the verge of describing
is to investigate the distribution of Πp,ε.
Now, let us present the simulation scheme. We repeat M = 1000 times the following steps for
each p ∈ {0, 10−4, 10−3, 2.5× 10−3, 5× 10−3}: at the mth iteration,
• for every θ ∈ Θ, draw under PM (θ) two independent n-tuples with n = 1000 that we denote
by (S1(θ), . . . , Sn(θ)) and (S
′
1(θ), . . . , S
′
n(θ));
• for every θ ∈ Θ, perturb the second random sample by introducing, for all i ≤ n, S′′i (θ) =
⌈(1 + p)S′i(θ)⌉;
• in order to compare the two independent collections {(S1(θ), . . . , Sn(θ)) : θ ∈ Θ0} and
{(S′′1 (θ), . . . , S′′n(θ)) : θ ∈ Θ0}, apply the multiple pairwise comparisons of empirical distri-
butions of sample sizes at decision test procedure presented in the previous subsection (with
B = 1000 and ε = 10−6), therefore yielding a single p-value Πmp,ε.
Based on this simulated dataset, we can estimate accurately the cdf u 7→ Pp(Πp,ε ≤ u) of Πp,ε in
each configuration. We finally represent in Figure 8 those estimated cdfs. The fit to a Uniform
distribution over [0, 1] under the null (i.e. when p = 0) is excellent. In addition, the procedure
exhibits good performances in terms of power when p ≥ 2.5 × 10−3. This is a very good result,
given the mean sample sizes at decision reported in Table 30 (they approximately range between
800 and 13000).
A.5 A summary of the results of the simulation studies carried out for
this article.
In this final section, we report summaries of the results of the simulation studies carried out for
this article.
• Tables 12 to 19 provide empirical coverage of the confidence intervals obtained under iid
gb-balanced sampling scheme (Tables 12 and 13), iid g⋆-optimal sampling scheme (Tables 14
and 15), g⋆n-adaptive sampling scheme (Tables 16 and 17), and g
a
n-adaptive sampling scheme
(Tables 18 and 19). See Section 6.3 for more details.
• Tables 20 to 27 provide the empirical means and standard deviations of a criterion comparing
the optimal widths of confidence intervals with the widths of confidence intervals obtained
under iid gb-balanced sampling scheme (Tables 20 and 21), iid g⋆-optimal sampling scheme
(Tables 22 and 23), g⋆n-adaptive sampling scheme (Tables 24 and 25), and g
a
n-adaptive
sampling scheme (Tables 26 and 27). See Section 6.4 for more details.
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Figure 8: Illustrating the sensibility of our tailored test for multiple pairwise comparisons of
empirical distributions of sample sizes at decision. We represent the estimated cdf u 7→ Pˆp(Πp,ε ≤
u) for p = 0 (rightmost curve) to p = 5 × 10−3 (leftmost curve). We use a logarithmic scale on
the x-axis. A vertical and an horizontal lines at the reference level α = 5% are drawn.
• Tables 28 and 29 respectively provide empirical type I and type II errors obtained under iid
gb-balanced, iid g⋆-optimal, g⋆n-adaptive, and g
a
n-adaptive sampling schemes. See Section 7.2
for more details.
• Tables 30 and 31 provide mean sample sizes at decision obtained when investigating the
adequateness of type I and type II errors, respectively, under iid gb-balanced, iid g⋆-optimal,
g⋆n-adaptive, and g
a
n-adaptive sampling schemes. See Section 7.3 for more details.
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q
u
en
ti
a
l
te
st
in
g
p
ro
ce
d
u
re
o
f
“
ψ
=
Ψ
(θ
)”
a
g
a
in
st
“
ψ
>
Ψ
(θ
)”
b
ei
n
g
p
ow
er
ed
a
t
Ψ
(θ
+
(0
,η
))
w
it
h
η
=
0
.0
5
a
n
d
fo
r
a
sy
m
p
to
ti
c
ty
p
e
I
er
ro
r
α
=
5
%
a
n
d
ty
p
e
II
er
ro
r
β
=
1
0
%
.
T
h
e
lo
w
es
t
a
n
d
h
ig
h
es
t
va
lu
es
a
re
em
p
h
a
si
ze
d
.
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